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ABSTRACT
In the adult rats an increase in adrenergic activity in the medial 
preoptic area (MPOA) and the mediobasal hypothalamus (MBH) occurs 
during the proestrous ’critical period’ preceding the preovulatory 
gonadotrophin (LH) surge. Similarly, using adult rats ovariectomized 
in the morning of dioestrus and injected (s.c.) immediately with 
oestrogen (OEg) it was found that adrenergic activity increased in 
the MBH but not the MPOA during the expected ’critical period’. It 
was suggested from these observations that an oestrogen stimulated 
increase in adrenergic activity in the MBH might be concerned with the 
surge output of gonadotrophin. In a previously reported ontological 
study of an oestrogen stimulated output of gonadotrophin, it was 
found that the occurrence of this neurohumoral event was critically 
related to the age and sex of the animal. An injection (s.c.) of 
oestrogen at noon (day 1) in infant rats at as early an age as 21 
days could elicit a surge of prolactin at 1800h the next day (day 2) 
and again on day 3; while a surge of LH occurred only at 1800h on day
3. Similar treatment of males at any age had no such effect. The 
purpose of the studies presented in this thesis was to investigate 
the development of central adrenergic systems concerned with the ontogeny 
and sexually differentiated output of gonadotrophin in response to an 
oestrogen stimulus in the infant rats.
Adrenaline concentration and the activity of its synthesizing enzyme 
(phenylethanolamine-N-methyl transferase, PNMT) present in the MPOA and 
MBH of oestrogen treated 16--22-day-old females and 22-day-old males 
were measured. This showed that adrenaline concentration and activity 
of PNMT in the MBH of oestrogen treated 22-day-old female rats increase
significantly (P<0.01) at 1600h both on days 2 and 3, 2h before the 
oestrogen dependent surge output of gonadotrophins (i.e. prolactin 
with or without LH) reach peak levels (1800h). Such an effect was 
not seen in similarly treated 16-day-old female and in 22-day-old 
male rats on day 3, with the exception of PNMT activity in 22-day- 
old males which showed an increase similar in the female. 22-day- 
old oil-treated male rats also showed an increase in PNMT in the MBH 
at 1600h which was not significantly different from those of 
oestrogen-treated rats. Noradrenaline and dopamine concentrations 
in the MBH of oestrogen treated 22-day-old female rats remained at 
baseline levels on days 2 and 3. In contrast to the MBH, the MPOA 
of these rats did not show an increase in either adrenaline concen­
tration or PNMT activity on day 3. Subsequent measurements of PNMT 
activity in the MBH of oestrogen treated 22-day-old female rats at 
4 hourly intervals throughout the days 2 and 3 showed the presence 
of a clear circadian rhythm with peak levels occurring at 1600h.
This rhythm appears to be dependant on the presence of plasma 
oestrogen and glucocorticoids since oil-treated or adrenalectomized 
22-day-old females did not show an increase in PNMT at 1600h.
In conclusion, it is clear that an increase in adrenaline concentration 
in the MBH of oestrogen treated 22-day-old female rats appears to be in 
synchrony with an increase in its synthesizing enzyme, PNMT. Further­
more, it is temporally related to surge output of gonadotrophins (LH 
and prolactin) which occur 2h later (1800h). Whether or not the 
temporal relationship occurring in the oestrogen-treated 22-day-old 
females is directly concerned with the output of gonadotrophins, or 
with other hormones which increase at the same time, is a question 
which requires investigation.
Chapter One
GENERAL INTRODUCTION
The preovulatory surge of gonadotrophins - luteinizing hormone (LH) 
and follicle stimulating hormone (FSH) in the rat is accompanied by 
a surge of a decapeptide known as gonadotrophin — releasing hormone 
(GnRH) (Sarkar et al., 1976; Schally, 1978; Guillemin, 1978). This 
decapeptide is released into hypothalamo-hypophysial portal vessels 
^^^ch connect the base of brain» in particular the median eminence 
(ME) with the anterior pituitary gland which is devoid of connecting 
neural pathways. Observations on the rat (Green & Harris, 1949) and 
mouse (Worthington, 1955) have shown that the direction of blood flow 
in the portal vessels is from the brain towards the gland. However, 
it has been observed recently that flow in the reverse direction can 
occur in part of the plexus of portal vessels and therefore, pituitary 
hormones may reach the hypothalmus (Page et al., 1976; Oliver et 
al., 1977). This later observation may account for the mechanism by 
which the pituitary regulates its own secretions (short-loop feedback). 
Using immunocytochemical techniques, it has been demonstrated that 
GnRH cell bodies in the rat are localized in and around the medial 
preoptic area and that their axon terminals project largely to the 
lateral aspects of the outer layer of tha median eminence (Kordon et 
al., 1974; Baker et al., 1975; King et al., 1982).
It is well established that the preovulatory surge of gonadotrophins 
accompanied by a surge of GnRH is not only preceded by but is also 
dependent on increased output of plasma oestrogen (Legan et al.,
1975 •; Fink, 1976) and furthermore, by a neural critical period, 
(Everett& Sawyer, 1950; Legan & Karsch, 1975)* This critical period
can be defined as about a 2h period on the proestrous afternoon 
during which if phenobarbitone is administered in anesthetic dose 
blocks the proestrous preovulatory LH surge.
Since previous studies have indicated that hypothalamic adrenaline 
might play a critical role in the output of LH surge during the neural 
critical period in adult cyclic rats (Mackinnon et al., 1983, 1985), 
the present studies were undertaken to investigate the ontogeny of 
hypothalamic adrenaline in the oestrogen-stimulated LH surge and 
secondly, its possible sexual differentiation.
Preovulatory increase of plasma oestrogen:
Follicles form the basic functional unit of the rat ovary and are 
responsible for the increased plasma oestrogen. Immature follicles 
known as primordial follicles grow initially under the local ovarian 
control forming primary follicles. Each primary follicle consists 
of an outer layer of theca interna cells which encircles the granulosa 
cells and a basement membrane separating internal theca from those 
of the granulosa. Granulosa cells also surround the innermost oocyte 
cumulus complex. The whole follicle is enclosed in a layer known as 
the theca externa which contains contractile elements. Further 
maturation of the primary follicles to antral or preovulatory follicles 
and their transformation into corpora lutea is regulated by a set of 
pituitary hormones namely FSH, LH and to a lesser extent prolactin 
which plays a supportive role (Richards, 1978; Henderson, 1979).
(a) Hormonal regulation of ovarian follicular development:
The length of the rat ovarian cycle (the oestrous cycle) lasts in a
majority of animals for 4 days and consists of proestrous, oestrous, 
metoestrous and dioestrous stages. Cyclic release of pituitary 
gonadotrophins interacts with ovarian follicular compartments in a 
highly integrated manner and is responsible for their development.
As development proceeds follicular fluid is retained within the growing 
follicle. FSH and oestrogen are found in this fluid which fulfils 
the essential requirement for further growth of the follicles (Richards, 
1978).
During the ear^oestrous period, FSH is the prime inducer of ovarian 
follicular maturation (Chappel et al., 1983). However both FSH and 
LH are required for oestrogen biosynthesis. One piece of evidence 
for this came from a study of immature rats in which they were hypo- 
physectomized at 28 days of age and 7 days later injected (s.c.) with 
ovine interstitial cell stimulating hormone (ICSH) and ovine FSH 
(Lostroh & Johnson, 1966). This study demonstrated that both ICSH 
and FSH were essential for follicular development and oestrogen 
production. It is widely accepted that the increased production of 
oestrogen from a preovulatory follicle when growing under the control 
of gonadotrophins is due to the co-operation of two types of ovarian 
cell, the theca interna and the granulosa. This ^o called two cell 
and two gonadotrophins concept (Fig.l) (Dorrington et al., 1977) is 
a useful model for understanding the biosynthesis of oestrogen in 
ovarian follicles. This concept is supported by a large number of 
both in vivo and in vitro studies. An in vivo, classical study by 
Falck (1959) in which both theca interna and granulosa cells were 
transplanted to the anterior chamber of the rat eye, showed that the 
joint action of two cell types was necessary for the biosynthesis of 
oestrogen. An autoradiographic study using rat ovarian tissue
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Fig. 1. Simplified diagrammatic representation of the two cell, two
gonadotrophins concept ,
A. C - 20; 22 - side chain'cleavage enzymes
B. 3p - hydroxy steroid dehydrogenase & isomerase
C. C - 17, 20 - side chain cleavage enzymes and 17p - hydroxy steroid
dehydrogenase
D. Aromatizing enzymes 
R. Receptor
demonstrated that radioactive LH was bound to theca interna cells 
whereas granulosa cells were devoid of such binding (Richards&
Midgley, 1976). In vitro studies of isolated theca interna cells have 
demonstrated that these cells secrete prédominently androgens [andro- 
stenedione and testosterone] in response to LH stimulation and have 
relatively little capacity to metabolise androgens to oestrogen 
(Fortune & Armstrong, 1977; Ahren et al., 1978). This is because of 
the low activity of the aromatizing enzymes, catalyzing; (a) the 
reduction of keto to hydroxyl group (3^-hydroxy steroid dehydrogenase),
(b) the cleavage of C10-C19 bond (C-10,19-side Chain cleavage enzyme),
(c) the introduction of double bonds which lead to the formation of 
oestrogen. In contrast to LH, FSH binds exclusively to the granulosa 
cells, however their binding capacity for LH is developed during late 
proestrous stage due to newly synthesized LH receptors on these cells 
which are induced by FSH and oestrogen (Richards & Midgley, 1976; 
Richards, 1979). In vitro studies have shown that granulosa cells 
lack the enzymes, C17, 20 - side chain cleavage enzymes and 17^- 
hydroxysteroid dehydrogenase which convert progesterone (C21-compounds) 
to androgens (C19-compounds) (Dorrington, 1977; Channing et al., 1980; 
Hillier, 1981). However, granulosa cells are capable of converting 
cholesterol to progesterone due to the presence of enzymes, C-20, 
22-side chain cleavage enzymes, 3p-hydroxy steroid dehydrogenase and 
isomerase which metabolise cholesterol to progesterone. Furthermore 
the granulosa cells can metabolise oestrogen when provided with 
androgens (Dorrington et al., 1975) due to the presence of enzymes 
which catalyze aromatization (Rase & Speroff, 1980). According to
the two cell, two gonadotrophins concept, FSH activates the aromatizing 
enzymes and furthermore, stimulates progesterone biosynthesis in the 
granulosa cells. LH interacts with the theca interna through its
specific receptors and stimulates biosynthesis of androgens from 
cholesterol. Androgens diffuse through the basement membrane into 
the granulosa cells and are converted to oestrogen. Oestrogen with 
FSH, in turn, induces more LH receptors on theca interna cells and 
consequently an enhanced response to LH. This causes these cells to 
produce more androgens which diffuse into granulosa cells and con­
sequently a much higher output of oestrogen. This intra-ovarian 
positive feedback effect of oestrogen is primarily considered to be 
responsible for the preovulatory rise of oestrogen which occurs during 
late dioestrus and early proestrus.
(b) Negative feedback;
The rising titers of oestrogen on late dioestrous initially induce 
a longloop negative feedback effect on gonadotrophins - LH and FSH 
(Martini et al., 1968a,b; McCann & Ramirez, 1964). Current radio­
immunoassays are probably not sensitive enough to detect small 
fluctuations in plasma gonadotrophin concentrations in intact cyclic 
rats, except on the proestrous day. Therefore evidence for negative 
feedback is derived, largely from studies on ovariectomized rats.
The removal of rat ovaries leads to increased pituitary and plasma 
gonadotrophin levels, and was first described by Moore & Price (1932). 
Furthermore, it was found that the administration of exogenous oestrogen 
to the ovariectomized rats caused LH levels to decrease.
More recently, in confirmation of previous studies, an investigation 
involving long-term ovariectomized rats with indwelling atrial cannulae 
demonstrated that subcutaneous administration of a heavy dose of 50mg 
oestradiol benzoate depressed the enhanced post-ovariectomy plasma 
LH concentrations which occurs in a pulsatile manner (Blake, 1977).
The complex series of neural events involved in negative feedback are
not fully understood. It is generally accepted, however, that the 
mechanisms underlying the post-ovariectomy pulsatile release of LH 
lies within the mediobasal hypothalamus (MBH) and, furthermore, its 
interation with the anterior pituitary is essential for mediating the 
feedback. Evidence for this comes largely from three different types 
of investigation. Studies pertaining to the interaction between the 
pituitary and brain suggest that pituitary LH release is modulated 
by GnRH output since portal plasma GnRH concentrations are increased 
in ovariectomized rats (Sarkar & Fink, 1980; Sherwood & Fink, 1980).
In confirmation of this work, an in vitro study showed that anterior 
pituitary fragments from ovariectomized rats released LH in a pulsatile 
manner only when driven by the infusion of pulsatile GnRH in the medium 
(Osland et al., 1975). In another investigation, steel cannulae con­
taining oestradiol were implanted stefeotaxically into the mediobasal 
hypothalamus (MBH), anterior pituitary, globus pallidus and supra- 
chiasmatic region of ovariectomized rats (Ramirez et al., 1964). The 
data showed that implants of the anterior pituitary or the MBH prevented 
the post-ovariectomy rise in LH concentration whereas implantation 
into other regions showed no such effect. This study clearly in­
dicated that the MBH and anterior pituitary were the site of negative 
feedback. In the third type of study using female rats, surgical cuts 
were made stereotaxically either between the medial preoptic area 
(MPOA) and the MBH or a complete deafferentation of the MBH was under­
taken. These animals were ovariectomized and then implanted with 
indwelling atrial cannulae for the collection of serial blood samples 
(Blake & Sawyer, 1974). This study demonstrated that the MPOA-MBH 
axis and complete-deafferentation of the MBH did not reduce the post­
ovariectomy rise in LH when compared to non-deafferentated ovariectom­
ized rats. Furthermore, this study implied that MPOA was not the site
the negative feedback since the enhanced post-ovariectomy LH levels
were found even after surgical cuts were made between the MPOA and 
MBH.
The subcellular effects of oestrogen in mediating the negative feed­
back are probably achieved through genomic mechanisms. Autoradiographic 
studies have shown that nuclei of pituitary gonadotrophs concentrated 
radioactive oestradiol (Stumpf, 1971). Moreover,, the removal of the 
negative feedback effect of oestrogen changed the pituitary sensitivity 
by increasing the density of GnRH receptors (Drouin et al., 1976;
Drouin & Labrie, 1981). The post-ovariectomy rise in LH concentration 
is probably due to an enhanced responsiveness of the anterior pituitary 
to GnRH. Recently, the possibility of a direct effect of oestrogen 
on plasma membrane has gained favour as oestrogen appears to alter 
ionic channels (Kelly, 1982). An electrophysiological study on guinea 
pig MBH demonstrated some immediate alterations in the electrical 
activity in response to oestrogen (Kelly & Ronnekleiv, 1982). However, 
a similar demonstration of GnRH neurones responding to oestrogen in 
the rat MBH has not been reported in the literature. Such a study 
might provide new dimensions in our understanding of feedback of 
oestrogen in LH release.
(c) Positive feedback:
It IS generally accepted that the preovulatory surge in outputs of 
pituitary hormones, prolactin (Frantz et al., 1972; Kalra et al., 1973; 
Neil, 1974; Leong et al., 1983), corticotropin (ACTH, Buckingham et 
al., 1978) and thyrotrophin (TSH, Brown-Grant et al., 1977; Buckingham 
et al., 1978) is preceded by enhanced plasma oestrogen levels origin­
ating from the ovarian follicles. These enhanced levels of oestrogen
10
which are achieved for a specific duration of time (both parameters 
being species specific) between the dioestrous and proestrous stage, 
elicit a long-loop positive feedback on gonadotrophins - LH and FSH 
(Fink, 1979; Chappel et al., 1983),
It is well established that an increase in the concentration of plasma 
oestrogen is an essential requirement for the preovulatory surge 
of LH release which causes ovulation (Brown-Grant et al., 1970;
Fink, 1976; Chappel et al., 1983). Evidence to support this comes 
from a study by Ferin et al. (1969) in which it was shown that anti 
sera, which blocked the biological activity of oestradiol_17^, when 
administered (i.p.) to immature rats treated with pregnant mare serum, 
also blocked ovulation. Furthermore, in these 'blocked' rats, diethyl— 
stilboestrol (a synthetic oestrogen which does not bind to the antisera) 
restored ovulation. Further evidence was derived from studies with 
rats ovariectomized in the morning of dioestrus and injected (s.c.) 
immediately with oestradiol benzoate (OEg) (acute model). This caused 
a proestrous-like surge the following evening while the control group 
of ovariectomized rats injected with oil vehicle showed no such effect 
(Tapper et al., 1974). In another study rats were ovariectomized and 
5 to 8 weeks later injected (s.c.) with OEg (chronic model). This 
steroid stimulus caused a proestrous-like LH surge 78h after the initial 
injection (Aiyer et al., 1976). The mechanism by which oestrogen induces 
a positive feedback response of LH is not fully understood. However, 
it is generally accepted that oestrogen brings this about by its effects 
at both pituitary and hypothalamic levels. Using an oestrogen exchange 
assay in which rats were ovariectomized and injected (i.v.) with 
saturating levels of oestrogen, oestrogen binding to its receptors 
was measured (Clark et al., 1982). This study demonstrated that oestrogen
11
binding occurred not only at the pituitary level but in discrete areas 
of the hypothalamus (MPOA and MBH) and the brain stem.
Two phenomena have emerged in order to describe the oestrogen response 
at the pituitary;
(a) Pituitary responsiveness:
this is described as its capability to release LH and FSH in response 
to GnRH. Pituitary responsiveness increases between the afternoon 
of dioestrous and that of proestrous whereas it is negligible during 
other days of the oestrous cycle. Using intact regularly cyclic rats 
administration of GnRH through the external jugular vein showed that 
LH in the peripheral plasma was significantly higher during the proestrous 
afternoon as compared to other days of the cycle (Aiyer et al., 1974a). 
Similarly, in another study using acutely ovariectomized rats, it was 
demonstrated that the enhanced sensitivity of the pituitary to GnRH 
during proestrus depends on the increase in plasma oestrogen which 
precedes the preovulatory surge of LH, no effect having been seen in 
ovariectomized rats (Aiyer & Fink, 1974). Furthermore, administration 
of. an antioestrogen (ICI46474) on dioestrus reduced the LH response 
to GnRH injected (i.v.) on the afternoon of proestrous which implies 
that the essential role of oestrogen in enhancing the pituitary res­
ponsiveness to GnRH is indispensable. These in vivo results are 
supported by an in vitro study using pituitary fragments which clearly 
indicated that the proestrous pituitary was much more sensitive to GnRH 
as compared to pituitary fragments taken on other days of the cycle 
(Waring & Turgeon, 1980). The mechanism by which eostrogen increases 
pituitary responsiveness is probably through genomic mechanisms by 
enhancing the number but not the affinity of GnRH receptors. The 
number of pituitary GnRH receptors parallels the magnitude of the LH
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output in response to GnRH (Ferland et al., 1981); and it has been 
demonstrated that the number of GnRH receptors varies markedly during 
the oestrous cycle in rats, more receptors being found during proestrus 
than at any other time of the cycle (Savoy-Moore et al., 1980; reviewed 
by Clayton & Catt, 1981.
(b) Self-priming effect:
The preovulatory output of LH and FSH is dependent not only on oestrogen 
sensitization of the pituitary, but also on a self-priming effect of 
GnRH. This is described as the oestrogen-primed gonadotrophs ability 
to release a greater amount of both LH and FSH in response to a second 
bolus of GnRH as compared to the first. Thus an investigation using 
three groups of rats (intact cyclic, acutely ovariectomized injected 
with oil vehicle and acutely ovariectomized injected with OE2) demon­
strated that the proestrous output of LH into peripheral plasma was 
much greater in response to the second bolus of GnRH injected (i.v.) 
one hour after, as compared to oestrus, mestoestrus and dioestrus 
stage of the cycle (Aiyer et al., 1974b). The ovariectomized-0E2 
treated animals showed that the self-priming effect of GnRH was similar 
to that obtained in proestrous animals but the ovariectomized-oil 
treated were devoid of such effect. The FSH response to the second 
bolus of GnRH, given one hour after the first, was found to be too 
small to be significantly different from that of the first FSH response. 
Using proestrous anterior pituitary fragments in a perfusion system. 
Waring and Turgeon (1980) have demonstrated the ’self-priming’ effect 
of GnRH in releasing LH which was similar to that in vivo.
Intra-cellular mechanisms involved with GnRH self-priming are still 
not fully known. However, the synthesis of new protein and functional 
integrity of microfilaments within the gonadotroph have been shown
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to be an essential part of the mechanism. Evidence for synthesis of new 
protein came from an investigation by Pickering and Fink (1976) in which 
inhibitors of protein synthesis (cycloheximide, puromycin and actinomycin) 
were either injected (i.v.) into proestrous rats or introduced to medium 
perfusing fragments of anterior pituitary from proestrous animals. This 
in vitro investigation demonstrated that the inhibitors had little effect 
on the first exposure to GnRH. However, a second exposure to GnRH 
significantly reduced LH output. It was thought that the synthesis of 
new protein caused the formation of new LH molecules during the self­
priming of GnRH, but the assessment of measurement both of gonadotrophins 
released and in the pituitary did not support this hypothesis (Pickering & 
Fink, 1979, Speight & Fink, 1981). In a recent study using two-dimensional 
gel electrophoresis,newly synthesized protein, present in the hemi- 
pituitary exposed to GnRH, was extracted and characterized (Curtis et 
al, 1985). This study showed that GnRH priming was associated with the 
synthesis of a new high molecular weight protein and post-translational 
changes in two previously existing proteins; the synthesis of new LH, 
however, was not involved. The dependence of GnRH-priming on cellular 
microfilaments was investigated by Pickering & Fink (1979). This 
investigation showed that cytochalasin B (a potent inhibitor of the 
functional integrity of microfilaments) when infused into the medium 
perfusing hemipituitaries, inhibited the enhanced output of LH in 
response to asecond bolus of GnRH.
The role of microfilaments in the self-priming effect of GnRH has been 
further studied using proestrous mice hemipituitaries perfused for 
two consecutive hours with or without cytochalasin B (Lewis et al.,
1985). In this study, the pituitary gonadotrophs were identified using 
immunocytochemical techniques and the ultrastructural changes in
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gonadotrophs exposed to GnRH were characterized by electron microscopy. 
This study, a confirmation of the previous investigation of Pickering 
& Fink (1979) demonstrated that the output of LH in response to the 
first bolus of GnRH was unaffected by cytochalasin B, but the enhanced 
output of LH in response to the second bolus was abolished. Moreover, 
with respect to the ultrastructural correlates, it was shown that the 
exposure of proestrous anterior pituitary in vitro to the first bolus 
of GnRH resulted in the formation of smaller secretory granules and 
their migration into the marginal zone beneath the plasma membrane,.
This was also associated with longer microfilaments and changes in 
their orientation, in that they came to lie in close proximity to the 
plasma membrane. The injection of a second bolus of GnRH increased 
further the migration of smaller secretory granules towards the periphery 
of the plasma membrane and caused changes in orientation of the micro­
filaments. Moreover, a significant drop in the secretory granules 
was observed after the second bolus. The functional integrity of micro­
filaments and processes leading to the migration of smaller secretory 
granules towards the periphery of the plasma membrane during GnRH self­
priming, is clearly associated with the output of a readily releasible 
pool of gonadotrophins.
The neural ’critical period*
It is well accepted that the positive feedback response to oestrogen
is mediated at the MPOA—MBH unit which is involved in the synthesis
and output of gonadotrophin releasing hormone. Furthermore, the response
is also dependent on the establishment of a neural ’critical period’
(reviewed by Fink, 1979; and Kalra & Kalra, 1983). Indications that
oestrogen mediates its effects at the MPOA and MBH came as a result
3
of autoradiographic studies in which it was demonstrated that [ H]-
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oestradiol was concentrated at these discrete areas of the hypothalamus 
(Pfaff, 1968; Stumpf, 1968; Pfaff & Keiner, 1973). However, electro­
stimulation of the MPOA using acutely ovariectomized rats injected 
(s.c.) with oestradiol benzoate (OE2) showed a facilitation of GnRH 
output into the hypothalamo-hypophysial portal vessels (Sherwood et 
al., 1976). This facilitatory response of OE2 was, however, ineffective 
when the MBH was electrically stimulated. Similarly, another study 
showed that an acute horizontal,section placed stereotaxically at the 
level of the anterior commisure just above the MPOA of cyclic rats, 
prevented ovulation (Kawakami & Terasawa, 1972). Furthermore, stainless 
steel cannulae filled with oestradiol when implanted into the MPOA 
of actuely ovariectomized rats with their hypothalamic connections 
intact, evoked the LH surge, yet similar stimulation of the MBH was 
devoid of such an effect (Goodman, 1978). Previous classical concepts 
pertaining to the stimulatory effect of oestrogen at the MPOA have 
implied that its action is mediated through genomic mechanisms (Pfaff 
& Keiner, 1975; King et al., 1982). However, a combined autoradiographi^/
immunocytochemical technique has failed to demonstrate the incorporation 
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of [ H]-oestradiol into the nuclei of GnRH cell bodies; instead the 
tritiated steroid was taken up by small neurones lying in close proximity 
to GnRH containing neurones (Shivers et al., 1983). This implies that 
mechanisms involved with oestrogen stimulation other than genomic 
activation, may be operative at GnRH synthesizing cell body level.
The establishment of the neural ’critical period’ in response to oestrogen 
occurs in the afternoon of proestrus in cyclic rats. This is defined 
as an interval on the afternoon of proestrus during which the admin­
istration of central nervous blocking agents, prevented ovulation the 
following day (reviewed by Everett, 1964). Evidence for a neural ’critical
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period’ is derived from the observation that pentobarbital anaethesia 
administered during a limited period of the proestrous afternoon (1400- 
1600h) delayed the occurrence of the LH surge and ovulation by 24h 
(Everett & Sawyer, 1950),whereas injection (i.p.) of pentobarbital 
either earlier or later than the critical period,had little or no effect 
on the preovulatory LH surge or ovulation. In our colony,rats maintained 
under a controlled lighting regime (lights on; 0600-2000h) have a critical 
period between 1430-1700h,while the LH surge occurs between 1700-1900h 
and ovulation between0200-0400h of oestrus (Sarkar et al., 1976). 
Ifentobarbital does nbt seem to diminish or abolish the anterior pituitary 
response to exogenous GnRH and therefore it is likely that it affects 
the neurogenic mechanisms of the brain involved in the release of GnRH 
(reviewed by Barraclough & Wise, 1982; and Barraclough et al., 1984). 
Neural mechanisms underlying the critical period are still unclear, 
but it is likely that both the MPOA and MBH are involved. Several 
reports have demonstrated that prostaglandins, opioids and neurotrans­
mitters, in particular catecholamines, are involved with the critical 
period (described above) which pixcedes the 0E2-stimulated LH surge and 
which is presumably associated with the release of GnRH into the 
hypothalamo-hypophysial portal vessels (reviewed by Ojeda et al., 1981; 
Barraclough & Wise, 1982; and Kalra & Kalra, 1983).
a. The role of prostaglandins in the output of GnRH:
It is generally accepted that prostaglandin E2 (PGE2) is involved in the 
output of GnRH (presumably during the ’critical period’) by acting on 
the MBH, in particular the ME (reviewed by Ojeda et al., 1981). Evidence 
to suggest that PGE2 may play a role in the output of GnRH came from a 
study in which the blockade of LH output as a result of stereotaxic 
infusion of either adrenergic, dopaminergic, serotonergic or cholinergic 
receptor blockers into the Illrd ventricle of long-term ovariectomized
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rats was not only reinstated but also enhanced by the infusion of PGEz 
into the Illrd ventricle (Harms et al., 1976). This probably implies 
that PGE2 acts directly on GnRH neurones in order to release GnRH into 
the hypothalamo-hypophysial portal vessels and hence LH output. 
Similarly, another study showed that blockade of prostaglandin synthesis 
with indomethacin prevented the oestrogen-progesterone induced output 
of LH in long-term ovarectomized rats when indomethacin implants were 
placed in the MBH before the occurrence of the LH surge (Ojeda et al., 
1975). The mechanisms of synthesis of prostaglandin E2 and its role in 
eliciting GnRH output has recently been delineated (reviewed by Negro- 
Villar et al., 1980; and Ojeda et al., 1981). Unlike most other hormones 
it probably acts as a local hormone which is synthesized within the 
MBH under the influence of neurotransmitters, in particular, catechol­
amines (Ojeda et al., 1979). In this study by Ojeda et al, using MBH 
and ME fragments of the rat brain in a perfusion system, it was demon­
strated that the infusion of NE into the medium was more effective 
than DA in releasing PGE2 concomitant to the GnRH output. The operative 
role of PGE2 on GnRH output is probably through the mobilisation of 
intracellular and extracellular calcium ions (Ojeda & Negrp-Vilar, 1984) . 
However, a significant portion of the PGE2 effect on GnRH release is in­
dependent of extracellular Ca since the complete omission of Ca^^ in 
the medium perfusing the ME did not prevent GnRH release in response 
to the depolarization of ME with 56mM K (Ojeda & Negro-Villar, 1985). 
Furthermore, in this study depletion of intracellular Ca stores by 
incubation with Ca^"^ ionophore, A23187 in a medium without C a a n d  
containing EGTA, almost completely blocked the subsequent GnRH response 
to PGE2. This suggests that intracellular Ca^^ stores are essential 
in mediating the PGE2 effect on GnRH output.
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b. The role of opioids in the output of GnRH;
Several studies have demonstrated that endogenous opioids induce inhibitory 
effects on the output of GnRH. It is possible that the removal of 
this inhibitory effect during the 'critical period'might disinhibit 
a preovulatory GnRH surge (as reviewed by Kalra, 1982; and Kalra &
Kalra, 1983). Thus the administration (i.p.) of morphine (an opiate 
agonist) to proestrous rats prior to the'critical period'blocked ovulation 
the following day (Barraclough & Sawyer, 1955). Similarly, in other 
studies the administration of morphine to intact or ovariectomized 
steroid-primed rats blocked the LH surge (Pang et al., 1977; leiri 
et al., 1980; Kalra & Simpkins, 1981). Evidence to suggest that the 
inhibitory effect of morphine occurs at the level of opiate receptors 
came from investigations in which it was demonstrated that a specific 
opiate receptor antagonist, naloxone, stimulated LH release in intact 
and steroid-primed rats (Meites et al., 1979; Kalra et al.rj 1981). 
Presumably the inhibitory influence of opioid peptide neurones on GnRH 
neurones was prevented. The mode of action of endogenous opioids in 
the regulation of GnRH output is not fully understood, but it is generally 
accepted that the removal of an inhibitory effect of opioids allows 
an enhanced turnover of catecholamines (NA & A) which apparently in­
fluence the release of GnRH (Kalra, 1982; Kalra & Kalra, 1983). The 
mechanisms by which endogenous opioids exert their inhibitory effect 
on catecholamines is still unclear (Kalra, 1981). However, the effects 
at the opiates have been localized to the MPOA and the MBH, and may 
involve modulatory changes in catecholamine neurotransmission (Kalra,
1981).
c. The involvement of catecholamines during the neural critical period; 
Several studies have demonstrated that an enhanced neurotransmission, 
in particular of catecholamines (DA, NA & A) which apparently occurs
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during the neural'critical period, participates in the output of GnRH 
and hence the LH surge and ovulation (Weiner & Ganong, 1978; Barraclough 
& Wise, 1982; Kalra & Kalra, 1983; Barraclough et al., 1984). However, 
the many neuropharmacological studies that have been attempted in order 
to determine a functional role for catecholamines in the regulation 
of LH release, are contradictory and to date, a clear concept pertaining 
to the involvement of a particular catecholamine cannot be put forward.
Dopamine :
A large number of studies have strongly suggested that the tubero- 
infundibular dopamine system participates in the output of GnRH (Lichten- 
steiger, 1970; Hokfelt & Fuxe, 1972; Lichtensteiger & Keller, 1974).
Cell bodies of the tubero-infundibular tract are mainly located in 
the arcuate nucleus and the axon terminals project to the ME (Ajika 
& Hokfelt, 1973 & 1975). Evidence that dopamine in the ME regulates 
GnRH output by its inhibitory role, came from a study in which the 
rate of decline in the catecholamine concentrations was measured after 
blockade of tyrosine hydroxylase (the rate-limiting enzymes for DA 
and NA) by £xl-methyl-p-tyrosine (o(MPT) (Lofstrom, 1977). It was found 
that turnover of dopamine was low at proestrus when compared with 
the other days of the cycle and Lbfstrom implied that disinhibition 
of DA on the GnRH nerve terminals induced the preostrous output of 
GnRH. In confirmation of this study, the infusion of dopamine into 
the Illrd ventricle (to avoid the blood brain barrier) of proestrous 
rats prior to the'critical period'blocked ovulation. This inhibitory 
role of dopamine is not generally accepted since in contradiction with 
the above study, the intraventricular infusion of dopamine into ovari­
ectomized oestrogen-primed rats showed a stimulatory effect on LH release 
and it was proposed that dopamine at the ME stimulates GnRH output
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(Vijayan & McCann, 1978). More recently, it has been shown that the 
dopamine incerto-hypothalmic tract, the cell bodies of which originate 
in the All group of the thalamus and project their axon terminals to 
the zona incerta (Zl) of the hypothalamus, appears to stimulate the 
output of the LH surge and consequently ovulation (Mackenzie et al.,
1984). In this study blockade of ovulation by pentobarbitone treatment 
was reinstated if DA was stereotaxically infused into the Illrd ventricle 
before the ’critical period’. Similarly, a dopamine antagonist, haloperidol, 
infused into the zona incerta of proestrous rats prevented ovulation. 
Furthermore, in this study, using an ovariectomized and oestrogen-primed 
rat model, LH release was stimulated when dopamine was placed stero- 
taxically into the zona incerta.
Noradrenaline and adrenaline:
The first evidence that catecholamines (NA & A) might be involved in 
the regulation of the preovulatory surge of LH came from a study in 
which it was demonstrated that dibenamine (i.v.) and SKF501 (i.p.)(both 
C<-adrenergic receptor antagonists) blocked ovulation when administered 
to cyclic rats(Everett et al., 1949; Sawyer et al., 1950). In confirmation 
of this study, intraventricular infusion of NA and A prior to the ’critical 
period’ induced ovulation in pentobarbital blocked rats (Rubinstein &
Sawyer, 1970). Several reports have appeared to demonstrate that central 
catecholamines are involved in LH release since the first evidence of 
c<-receptor involvement in the output of gonadotrophins was reported 
by Everett & Co-workers (1949). An autoradiographic study showed that 
tritiated oestradiol was concentrated in the nuclei of the cell bodies 
of catecholamines neurones at the brain stem (Sar & Stumpf, 1981).
This implies that genomic activation induced by oestrogen might be 
operative at the catecholamine cell body level. Subsequently, the
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idea was accepted that catecholamines have a mediatory role for oestrogen 
in eliciting the positive feedback response of LH (reviewed by Kalra 
& Kalra, 1983; and Barraclough et al., 1984). During the critical 
period catecholamines, mediating the positive feedback response to 
oestrogen, may provide a stimulatory effect on the preovulatory surge 
output of GnRH which, in turn regulates the LH output from the anterior 
pituitary. Neurotoxins such as 6-hydroxydopamine, when stereotaxically 
injected into the ventral noradrenergic bundle of the MPOA, disrupted 
the catecholamine system and this led to blockade of ovulation (Beneditti 
et al., 1976; Martinovic & McCann, 1977; Nicholson et al., 1978; Hanckle 
& Wuttke, 1979). With the advent of microdissection techniques and 
more sensitive catecholamine assays, it has recently been possible 
to measure catecholamines in discrete areas of the brain. A considerable 
increase in NA content of the rat suprachiasmatic nucleus was found 
during the afternoon of proestrus as compared to the morning. Further­
more, in this study the median eminence showed an increase in NA content 
from dioestrous to proestrous stage while dopamine remained at basal 
level during the oestrous cycle (Selmanoff et al., 1976). Since the 
measure of turnover of a neurotransmitter seems to be a more sensitive 
index of neuronal activity (Costa & Neff, 1977; Weiner, 1974), in another 
study using o<:MPT, changes in catecholamine turnover were measured in 
discrete areas of the rat brain on dioestrus and proestrus (Ranee 
et al., 1981). It was observed that a significantly higher NA turnover 
in the medial preoptic area (MPOA) occurred during the proestrous after­
noon and furthermore, a significant increase in NA turnover in the 
median eminence occurred at a later time concomitant with the LH surge. 
Ranee et al suggested that increased NA turnover in the MPOA might 
be the neural mechanism underlying the neural ’critical period’. However, 
a further study concerning NA turnover in pentobarbital treated proestrous
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rats did not support this suggestion since increased turnover of NA 
in the MPOA was found in pentobarbital blocked animals which was similar 
to that observed in control animals (Ranee & Barraclough, 1981). This 
suggestion is apparently supported by the observation that neurotoxin —  
(6-hydroxydopamine) induced degeneration of NA axons or lesions of 
the ventral noradrenergic bundle lead to the loss of ovulation. However, 
this loss is only temporary since ovulation returns, within three weeks 
(Clifton & Sawyer, 1979). An explanation which has been suggested is 
that NA axons regenerate after 2-3 weeks. It is equally possible that 
adrenaline axons were temporarily damaged and became operative at a 
later time, since the distribution of adrenaline axons is in parallel 
to that of noradrenaline axons (reviewed by Moore & Bloom, 1979). An 
overview of the anatomical studies indicates that the noradrenaline 
system in the rat brain is composed of two cell groups located at two 
sites in the brain stem (a) locus coeruleus (b) lateral tegmental.
Both of these sites contain NA cell bodies that project axons 
via the ventral noradrenergic bundle to nearly all discrete areas of 
the hypothalamus. However, noradrenergic input to the hypothalamus 
comes largely from lateral tegmental brain stem neurones (reviewed 
by Moore & Bloom, 1979). Although, in the past, there has been dis­
agreement over the existence of central adrenaline neurone systems 
due to the lack of techniques which could distinguish adrenaline from 
other catecholamines, recent enzymatic and immunohistochemical studies 
by Saavedra et al (1974b)and Hokfelt et al (1974) respectively, have 
revealed their existence. The enzymatic study measured the activity 
of phenylethanolamine-N-methyltransferase (PNMT) (the enzyme which 
converts NA to A, EC 2.1.1.28) in the rat brain nuclei. It was found 
that the FNMT activity was unevenly distributed both within the brain 
stem nuclei and the hypothalamic nuclei. The greatest PNMT activity
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was measured in two areas of the brain stem, A1 and A2 which largely 
contain the catecholamine nerve cell bodies (Dahlstrom & Fuxe, 1964). 
Moreover, high PNMT activity was present in the mediobasal hypothalamus. 
With the immunohistochemical technique for PNMT which agrees well with 
the enzymatic technique it has been found that the enzyme is dis­
tributed roughly in parallel with what has been earlier considered 
to be a noradrenergic pathway (Swanson & Hartman, 1975). This raises 
the possibility that mechanisms attributed to NA in the brain may be 
exerted in part by adrenaline. Based on the enzymatic and immuno­
histochemical findings it is well accepted that the perikarya of adren­
ergic neurones are situated in the brain stem, in particular the lateral 
reticular formation from which axons project to the medial preoptic 
area (MPOA), perifornical area (PFA) and the arcuate-median eminence 
area (MBH).
Evidence that adrenaline may be a more potent catecholamine involved 
with the LH surge came from a series of studies. Thus an intraventricular 
infusion of adrenaline into reserpine or pentobarbital-blocked rats 
was more successful than dopamine and noradrenaline in reinstating 
the preovulatory LH surge (Rubinstein & Sawyer, 1970) (reserpine, a 
depleter of catecholamine (CA) from the storage granules by inducing 
a slow release of CA from the granules by inhibiting Mg^ -ATP dependent 
granular uptake of CA]. In support of this study, it has been demon­
strated that the stereotaxic infusion of adrenaline into the 3rd ventricle 
of ovariectomized oestrogen-progesterone primed rats in stimulating 
the LH output was more potent than DA & NA (Vijayan & McCann, 1978). 
Recently, several reports have appeared which implicated a critical 
role of adrenaline in the control of the LH surge. Among these, a study 
involving a selective inhibitor of adrenaline biosynthesis, SKF64139
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(dichloro-tetrahydroisoquinoline) when administered (i.p., 50mg/kg) 
to long-term ovariectomized oestrogen-progesterone treated rats, 5-6h 
before the expected LH surge, completely blocked the output of the 
LH surge (Crowley & Cass-Terry, 1981). Furthermore, in another study 
to characterize further the role of central adrenaline in the neural 
regulation of the surge output of gonadotrophins (LH and prolactin) 
it was indicated that central adrenaline mediated the positive feedback 
response of ovarian hormones on LH secretion but not the oestrogen- 
induced increase in prolactin (Crowley et al., 1982). In parallel to 
the above studies, an investigation pertaining to indoleamines showed 
that p-clorophenylalanine (PCPA), a potent inhibitor of tryptophan 
hydroxylase, blocked the LH surge induced by oestrogen to ovariectomized 
rats which was reinstated by the injection (i.p.) of 5—hydroxytryptophan 
(5-HTP) at lOOh of the expected day of the LH surge (Coen & Mackinnon, 
1979). However, neurotoxin induced lesion of the 5-hydroxytryptamine 
(5HT) projections from the raphe nuclei were consistent with a normal 
occurrence of the LH surge, which contradicted the earlier suggestions 
that 5HT plays an essential role in the output of the preovulatory 
LH surge (Coen et al., 1983). This paradox was resolved from the ob­
servations by Coen et al (1983) that PCPA inhibited the activity of 
PNMT and hence the adrenaline concentration was affected. Therefore, 
the possibility arose that PCPA might be blocking the LH surge through 
its influence on the adrenaline system. In confirmation of this study, 
the measurement of adrenergic activity based on the rate of decline 
of adrenaline 2h after injection (i.p., 50mg/kg) of SKF 64139 suggested 
that adrenergic activity increased in the MBH of adult cyclic rats 
during the neural critical period and furthermore, it was inhibited 
by pentobarbital as the preovulatory surge concentration of LH and 
ovulation (Mackinnon et al., 1983). Another investigation using acutely
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ovariectomized oestrogen-primed rats showed that the increased adrenergic 
activity at the MBH was dependent on oestrogen, such an effect was not 
seen in the MPOA (Mackinnon et al., 1985).
In a previous study of ontology of the oestradiol benzoate (OE2) stimu­
lated gonadotrophin (LH) and prolactin surge, it was found that this 
neuro-humoral event could be elicited in 21-day-old female rats but 
not in 16-day-old females or males at any age (Puig-Duran & Mackinnon, 
1978a,b). These ontological studies are supported by others 
which indicated that in female rats the different nervous structures 
located in the anterior hypothalamic area involved in the positive 
feedback effect of ovarian steroid mature at about 22-days of age 
(Ojeda et al., 1971; Caldgaris et al., 1978, Moguilevsky et al., 1981; 
Moguilevskey et al., 1982).
Aims :
In the present work I have used the steroid-stimulated infant rat as an 
experimental model (Puig-Duran & Mackinnon, 1978a) to test whether or 
not the increase of adrenaline concentration in the MBH, which is 
temporarily related to the output of gonadotrophins in adult female 
rats (Sheaves et al., 1985a) also occurs in 0E2-stimulated infant 
females and furthermore, to characterize its possible involvement in 
the sexually differentiated positive feedback response to oestrogen.
In addition, since adrenaline is synthesized from noradrenaline in 
various brain areas (Ciaranello et al., 1969) by the spécifie enzyme, 
phenylethanolamine-N-methyltransferase (Pohorecky et al., 1969), the 
activity of this enzyme in the MBH and MPOA at pertinent times after 
the initial injection of oestradiol benzoate was also investigated.
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Chapter Two
GENERAL MATERIALS AND METHODS
The general materials and methods which have been used throughout this 
work are described in this chapter.
Animals
Male and female Albino Wistar rats were purchased as adults from Charles 
River, Kent, and when necessary mated in our animal house. The pregnant 
mothers were identified by palpation and caged individually until delivery 
In our colony, parturition usually occurred on either day 21 or 22 of 
gestation. The day of birth with respect to our litters was designated 
day 0 and pups were culled within 24 hours so as to restrict the litters 
to a maximum of eight. Since previous observations had shown that 
weaning does not affect the gonadotrophin response to an oestrogen 
stimulus, weaning took place at 21 days of age. All rats were maintained 
under conditions of controlled lighting (lights on: 0600-2000h) and 
temperature (22±2°C) and had free access to diet FFG [Dixon & Sons 
Ltd., Ware] and tap water. Immature rats of 16-25 day-old were used 
throughout this investigation. This chapter has been divided into four 
sections namely section ’A', 'B’, ’C  and ’D ’. Methods of measuring 
protein are described in the appendix.
SECTION ’A ’
RADIOIMMUNOASSAY OF LUTEINIZING HORMONE
1. Introduction
In a radioimmunoassay (RIA) minute quantities of a protein hormone 
are measured. This technique exploits the immunological properties
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of the hormone to be measured and its competition with labelled hormone
for a fixed number of binding sites on the antibody. This was introduced
by Berson et al., (1956) when they observed that plasma from patients
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receiving insulin could bind insulin labelled with I. They found 
that such a reaction was of an antigen-antibody nature and the component 
with antibody properties was identified as gamma-globulin. In vitro 
studies demonstrated that if unlabelled insulin was added to labelled 
insulin, competition between the two occurred for binding sites on 
the antibody, furthermore competition was found to be quantitative 
(Yalow & Berson, 1960). This reaction formed the basis of radioimmuno­
assay technique. Subsequently, a simple method of labelling tyrosine
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residues in a protein with I or I using chloramine-T as oxidant 
(Greenwood et al., 1963) enabled this technique to be routinely used 
for measuring hormones in biological fluids or tissues. The first RIA 
for rat luteinizing hormone (LH) was reported by Monroe et al. in 1968. 
Since this technique utilized highly purified rat LH for iodination 
and purified rat LH for immunization, this assay is known as rat-rat 
LH radioimmunoassy (RR rat LH RIA). This assay was much more sensitive 
than previously existing biological assay for quantifying LH levels. 
Although the first radioimmunoassay was capable of measuring LH levels 
in both pituitary extracts and samples of serum, it was still not possible 
to measure sequential samples of sera from the same rat since the volumes 
required were too great (500/^). A highly sensitive assay was subse­
quently developed by Niswender et al. in 1968 known as ovine ovine rat 
radioimmunoassay (00 rat RIA) which ensured that smaller volumes of 
sera could be measured. However, this microassay has certain limitations, 
at least 2 0 0 of serum is the absolute requirement of this assay. In 
certain instances, the volume of fluid available may be severely limited 
because of: (a) the need for specimens to be assayed in duplicate;
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(b) the physiological disruption attendant upon the collection of 
relatively large amounts of body fluids and, (c) lack of sufficient 
volume in collections taken from very small animals. These difficulties 
were solved when Naftolin and Corker (1971) scaled down the original 
RIA by Niswender et al. (1968) and made it possible to measure LH using 
samples of as little as lOpl. This assay is known as the ultramicromethod 
for the measurement of LH by RIA and this has been used in the present 
laboratory since it was set up in 1970.
2. Reagents 
2.1 Buffers
(a) Phosphate Buffered Saline (PBS) was made from 10 litres of 
0.14M NaCl containing 68.6ml 0.5M NaHgPO^, 137ml 0.5M NagHPO^, Ig 
thimersol, an antibacterial agent [Sigma Chemical Co. Ltd., U.K.] and 
the pH adjusted to 7.0 if necessary.
(b) 0.5M Phosphate Buffer for protein iodination 0.5M NaHgPO^ and 
0.5M Na2HP0^ were mixed in an approximate ratio of 1:8 to give a final 
pH of 7.5.
(c) 0.05M Phosphate Buffer 0.05M Na2HP0^ and 0.05M NaH2P0^ were 
mixed in an approximate ratio of 1:8 to give a final pH of 7.5.
(d) Special Buffer was made from ethylenediamine tetra-acetic 
acid [EDTA, a chelating agent; BDH, Dagenham], 0.05M in PBS, to which 
was added normal rabbit serum (NRS) to give a final dilution of 1:300 
of the NRS.
(e) Egg White Solution (EW) 1% (W/V) EW was made from 990ml PBS,
10ml 1:100 thimersol and lOg egg white. 5% (W/V) EW was made from 
99ml PBS, 1ml 1:100 thimersol and 5g egg white.
2.2 Protein for iodination purified ovine LH (OLH, LER 1056-C2) was 
kindly donated by Professor L. E. Reichert Jr. It had a biological
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•potency of 1.71XNIH-LH-S1 Units/mg by ovarian ascorbic acid depletion 
(OAAD) test and negligible, if any, TSH or FSH contamination. This 
material was dissolved in distilled water to give a concentration of 
1 Ff/jdand 5 /tC aliquots were stored in autoanalyzer vials and frozen 
at-20°C until ready to use.
2.3 Antibodies
(a) Antiserum to ovine LH (AOLH). This was raised in rabbits and 
kindly donated by Professor G. D. Niswender. The lyophilised material 
(AOLH, GDN-15) was dissolved in distrilled water to give a 1:400 dilution 
and stored in 1.0ml aliquots a t —20°C. When needed, the antiserum of 
the 1:400 dilution was further diluted to 1:32,000 with special buffer.
(h) Anti—Rabbit Gamma Globulin (ARGG). This was raised in donkeys 
and obtained from Burroughs Wellcome [Beckenham, Kent]. It was used as 
the precipitating antibody at a dilution of 1:16 in PBS.
2.4 Standards
A standard ovine LH preparation, prepared from pituitary (NIH-LH-S13) 
was obtained from the National Institute of Arthritis, Diabetes, Digestive 
Diseases & Kidney (NIADDK). The biological potency was estimated as
0.95 X NIH-LH-Sl units per mg by OAAD test and negligible if any, TSH 
or FSH contamination. The lyophilized standard was dissolved in 1% EW 
to concentrations of 0.25, 1.0, 2.0, 4.0, 8.0, 16.0 and 32.0/%g/l.
Aliquots of 50^  for each dilution were stored in colour-coded LP2 
tubes (Luckhams Ltd., Sussex) and frozen at -20°C until use.
2*5 Radio—iodination of LH protein. Radioiodination of ovine LH protein 
was performed by the method of Greenwood et al. (1963). All iodination 
procedure was carried out inside an enclosed hood (which was accessible 
through armlets and which had an extractor fan), housed in a special 
iodination room . The reaction vessel was an autoanalyzer vial, into 
which all reagents were injected.
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A 5 aliquot of OLH was buffered with 50/^ 0.5M phosphate buffer,
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followed by ImCi of sodium- I [specific activity : 16.8 raCi/jjg . Amersham
International, U.K.]. 2O/t0 of 0.0036M chloramine-T [BDH, Dagenham]
in 0.05M phosphate buffer was added in order to oxidize the iodide 
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and enable the I to attach the tyrosine residues of the protein.
The contents of the vessel were mixed for 30 sec. and the reaction 
terminated by the addition of 100jn£ of 0.0126M sodium metabisulphite 
[BDH, Dagenham] diluted in 0.05M phosphate buffer. The iodination 
mixture was loaded on to a column (1cm x 12cm) of Sephadex-G75 [Pharmacia 
Uppsala, Sweden] using a pasteur pipette which had been pre-rinsed in 
5% EW so as to minimize the absorption of protein on the glass. The 
sephadex had been pre-soaked in 0.05M phosphate buffer, 1ml of 5% EW 
passed through the column in order to minimize protein loss from the 
iodination mixture by adsorption. The protein was eluted with 0.05M 
phosphate buffer and 1ml fractions were collected in glass tubes [PTF104, 
Gallenkamp], each containing 1ml of 5% EW. The radioactivity in the 
fractions was measured with an X-ray Mini Monitor [Mini-Instruments, 
London] and revealed 2 peaks of radioactivity, an early peak of protein 
and a later peak of free iodine (Fig.2). The fraction of the initial 
peak with the most radioactivity was selected since it was consistently 
identifiable. This fraction was usable for at least 4-5 weeks if it 
was kept frozen at -20°C. For subsequent use in the assay, the labelled 
OLH was further diluted in 1% EW to give 5,000-7,000 CPM/50ylf in a 
Berthold Auto-Gamma Counter [LB MAG310, Germany].
2.6 Assay Method. All manipulations were carried out at 4°C on ice. 
Each component of the assay was added in a 50/(f volume. Serum samples 
were dispensed into disposable plastic LP2 tubes using a Finnpipette 
[Labsystems, Finland] while other reagents were dispensed using repettes 
[Jencone Scientific Ltd., Hemel Hempstead].
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Fig. 2. Separation of ^^^I-labelled ovine LH from ^^^-iodide and other
low molecular weight reactants, on a sephadex G-75 column.
The arrow indicates the column fraction containing labelled LH which
was collected for subsequent radioimmunoassays (see text). The
125second peak indicates the column fraction containing -iodide 
and other low molecular weight reactants.
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Each assay included;
(1) Three 'total count tubes', which contained 50/c£, of labelled OLH 
only, to record the number of counts added to every tube in the assay;
(ii) Reference tubes without antibody (Nil AOLH) run in triplicate,
to assess the amount of labelled OLH precipitated in the absence of the 
antibody;
(iii) Reference tubes without unlabelled hormone (Nil OLH), run in trip­
licate, to assess the maximum amount of labelled OLH that bound to AOLH 
in the absence of competing unlabelled LH;
(iv) A standard curve, run in triplicate;
(v) Aliquots of pooled rat serum samples, run in triplicate, to assesS 
the inter-assay variation;
(vi) Unknown samples run in duplicate.
The following timetable was followed;- 
Day 1 - Unknown serum samples (50/a£) were dispensed into LP2 tubes and 
1% EW and AOLH were added to these tubes and to the standards and serum 
pools; the Nil OLH tubes received an aliquot of 1% EW instead of un­
labelled hormone, and the Nil AOLH tube received special buffer in place 
of AOLH. All tubes were then whirlimixed briefly and left at 4°C for 
24h.
Day 2 - 5 0 ^  of labelled OLH containing approximately 5,000-7,000 C.P.M. 
was added to each tube; the tubes were whirlimixed briefly and left 
at 4®C for 48h.
Day 3 - No manipulations were performed.
Day 4 - 50//Z of ARGG was added to all tubes except the 'total counts
tubes'; the tubes were whirlimixed briefly and left at 4°C for 24h.
Day 5 - All tubes, except the 'total count tubes' were spun at 15,00g
in a refrigerated centrifuge at 4®C for 45 min. The supernatant con­
taining the unbound fraction, was aspirated and discarded, and the
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precipitate left in the tube was counted in a Berthold Auto-Gamma counter 
for 2 minutes.
2.7 Calculations. The counts in the Nil AOLH tube were subtracted 
from the counts in all other tubes and their individual counts were 
expressed as a percentage of the Nil OLH tube (maximum bound). The 
standard values were then plotted on a semi-logrithmic paper to give 
a standard curve from which the value of unknowns and pools were read 
off this curve (Fig.3). Duplicates of unknown samples in the same 
assay were with 10% of each other otherwise they were discarded and 
the assay repeated.
2.8 Reliability Criteria
Precision was estimated from the coefficient of variation which 
is calculated by expressing the standard deviation of a group of assay 
results of the same sample as a percentage of the mean value. There 
are two kinds of coefficients of variation,
(a) Inter-assay coefficient of variation. This was obtained by 
estimating the same sample, at least, in 9 separate assays.
(b) Intra-assay coefficient of variation. This was obtained by 
measuring, at least, 8 aliquots of the same sample in the same assay. 
Inter- and Intra-assay coefficients of variation are as follows ;-
Inter-assay coefficient of variation:
Mean Standard Coefficient of
(y^ /^1) deviation variation
No.
Pooled Serum 1 0.60 0.050(n=10) 8.25%
" 2 2.93 0.377(n=10) 12.79%
3 18.20 1.653(n=9) 9.08%
Mean of coefficients of variation = 10.04%
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Fig.3. A typical standard curve obtained by using NIH-LH-S13 
standards (0.25 - 32 jjg/1).
Each point is a mean of 3 determinations.
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Intra-assay coefficient of variation:
Mean Standard Coefficient of
deviation variation
No.
Pooled serum 1 0.57 0.10(n=10) 7.53%
2 3.08 0.31(n=8) 10.06%
3 19.52 0.83(n=10) 4.25%
Mean of coefficients of variation = 7.28%
2.9 Sensitivity and Specificity. According to the 'Approved Recommendation 
on Quality Control in Clinical Chemistry' (Buttner et al., 1980), sens­
itivity is defined as twice the standard deviation (2 x S.D) of the 
blank values. On the basis of this criterion and considering the reference 
tubes with Nil AOLH the sensitivity resulted in approximately 0.25 /Ig 
N1H-LH-S13/1 which gave a displacement of bound counts of about 10% (Fig.
3). This was considered to be the smallest amount of hormone which 
could be reliably measured. Values lower than this were considered 
to be non-detectable (ND). Serum samples in which the LH concentration 
was found to be too high to be read off the standard curve were considered 
to be greater than 3 2 [ > 3 2 ] .  The assay is considered to be highly 
specific for LH since the antibody does not cross react with either TSH 
or FSH (Niswender et al., 1968).
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SECTION 'B'
MICRODISSECTION OF DISCRETE HYPOTHALAMIC AREAS OF THE BRAIN
1. Introduction
When neurochemical studies are performed on brain samples from small 
animals, it is difficult to excise well defined areas with good repro­
ducibility by visual free-hand dissection. However, a micropunch 
technique developed by Palkovits (1973) has solved this difficulty and 
enables the removal of specific brain areas, nuclei, tracts and other 
sub-divisions of nuclei. This technique has been successfully applied 
in the determination of brain amines; serotonin (Saavedra et al., 1974a), 
noradrenaline and dopamine (Palkovits et al., 1974) and enzymes, 
phenylethanolamine-N-methyltransferase (PNMT) (Saavedra et al., 1974b) 
and serotonin synthesizing enzymes (Saavedra, 1977). Since the accurate 
measurements of catecholamines and PNMT activity present in discrete 
hypothalamic areas were the objectives of this study, the micropunch 
technique was used throughout. If post-mortem changes in brain amines 
and the loss of PNMT activity are to be avoided, the tissue must be 
frozen as soon as possible after death. In the micropunch method, 
this is fulfilled because freezing of the brain is an essential require­
ment.
2. The Micropunch Technique 
This technique requires:
(a) Removal of the brain. Decapitation is the most practical 
method of killing (Palkovits & Brownstein, 1983) and this was adopted 
throughout the present work. Only four immature rats of the same sex 
were kept per cage [Dimensions: 15" x 10" x 7" (length x width x height)] 
and of these a maximum of two were used per decapitation session to
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minimize stress effects. Rats were decapitated with large scissors 
and occipital muscles from the occipital bone were cut off to expose 
the foramen magnum. With bone nibblers introduced into the foramen 
magnum, two parallel cuts were made through the parietal bone sutures 
extending rostrally as far as bregma. The bone was then lifted forward 
and cut off at the point of attachment. It was important to keep the 
blade parallel to the skull in order to avoid any damage to brain tissue 
The brain was then elevated at the rostral end and the optic nerves 
severed with small scissors. The brain was removed to a cold plate 
resting on ice, with ventral side of the brain lying uppermost. A 
cut was then made in the coronal plane at the rostral end of the optic 
chiasma, leaving the optic nerves intact. A second cut was made near 
the caudal end of the mammilary bodies. This portion of the brain 
which includes the whole hypothalamus was mounted on its caudal end 
on a microtome chuck onto which 200^1 water had been pipetted. The 
chuck was immediately placed in solid CO2 (dry ice). The whole pro­
cedure of decapitation, removal of the brain and placing on solid CO2 
was completed within 2 minutes. If the brain was not immediately 
required for sectioning, it was wrapped in cling foil and stored at 
-70°C.
(b) Sectioning frozen brains. The frozen brains mounted on their 
chucks were placed initially in a cryostat [Slee, ^London] at -12°C 
to equilibrate for at least 30 minutes, before sectioning. Individual 
chucks were then attached to the microtome and serial coronal sections 
(250pm) were cut. An anti-roll device consisting of a plastic plate 
attached to the microtome was used to flatten out the sections. The 
frozen sections were mounted on glass slides by secured partial thawing 
within the cryostat (by rubbing the under surface of the slide with 
a finger) and they were then rapidly refrozen. Two serial sections
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rostral to the caudal end of the anterior commisure which approximately 
correspond to 7020-6570pm in the rat brain Atlas (Konig & Klippel,
1963) were collected for punching out MPOA. Further serial sections 
were' taken caudal to the optic chiasma and until the pituitary stalk 
was seen. These were used for punching out the MBH. These sections 
correspond to approximately 4890-4230pm (Kbnig & Klippel, 1963).
(c) Removal of brain samples. With the use of a dissecting 
microscope [Carl Zeiss, Germany] a hollow needle punch with an 
internal diameter 0.85mm, a small metal spring device attached to 
the stylet which ensured release of tissue samples (Fig.4) brain samples 
were removed. The samples were placed on a slide lying on a dark plastic 
container filled with solid CO2 thus avoiding any likelihood of sections 
becoming thawed.
3. Punching out of medial preoptic area and mediobasal hypothalamus 
The MPOA was punched out bilaterally from each of the two rostral sections 
at a point half-way up the 3rd ventricle and 1mm lateral to it (Fig.5a). 
The MBH was punched out from 3 or 4 serial sections after the lateral 
recessus of the 3rd ventricle appeared (Fig.5b).
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Fig.4. Diagrammatic representation of the:
(a) stainless-steel punch equipped with a stylet (internal) 
diameter, 0.85mm).
(b) stainless-steel stylet equipped with a small spring.
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Fig.5a. Simplified diagram of a coronal section (containing anterior 
commisure) of the rat brain showing the location of the medial 
preoptic area (MPOA). The circle in the diagram represents the 
inner diameter of the dissecting needle (0.85mm).
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Fig.5b. Simplified diagram of a coronal section (containing lateral 
recessus of the Ilird ventricle) of the rat brain showing the location 
of the medio-basal hypothalamus (MBH). The solid circle in the 
diagram containing arcuate nucleus-median eminence (MBH) represents 
the inner diameter of the dissecting needle (0.85mm).
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SECTION 'C
RADIOENZYMATIC ASSAY OF CATECHOLAMINES
1. Introduction
A number of sensitive and specific radioenzymatic methods have been 
developed for the determinations of small amounts of catecholamines 
and other compounds carrying a catechol moiety. These methods are 
based on the enzymatic méthylation of the catechols using catechol-o- 
methyl transferase (COMT) and s-adenosyl-methionine (SAM) as the methyl 
donor.
The original assay reported by Engelman et al. (1968) for measuring 
totalp-hydroxylated catecholamines in urine and plasma stimulated 
much interest because of the 10-fold increase of sensitivity over 
conventional spectrofluorometric methods. Thus Nikodijeyic et al.
(1969); Engelman and Portnoy (1970); Passon and Peuler (1973), 
improved the original method by introducing a thin layer chromatography 
(TLC) step for the separation of noradrenaline (NA) from adrenaline 
(A); however, it could only be applied to tissues containing p-hydr- 
oxylated catecholamines. Since ^ -hydroxylated catecholamines (NA &
A) and dopamine (DA) are equally good substrates for COMT, (Guldberg 
and Marsden, 1975), methylated products of both amines would be re­
covered. Thereafter, other workers made attempts to separate these 
amines. Thus Coyle and Henry (1973) reported the use of organic 
extraction together with a selective periodate oxidation of NA to separate 
it from DA. Similarly, Cuello et al., (1973) reported the use of COMT 
for the enzyme radiochemical assay of dopamine together with paper 
chromatography for the separation of dopamine from noradrenaline and
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adrenaline. In subsequent years, various modifications were made to 
improve the method and to increase the sensitivity and specificity 
of the assay (Palkovits et al., 1974 ; Daprada and Zurcher, 1976;
Gauchy et al., 1976; Weise and Kopin, 1976; Peuler and Johnson, 1977). 
Finally, Sailer and Zigmond (1978), improved the method still further 
making it sufficiently sensitive to analyze small amounts of DA, NA, 
and A in either plasma or in tissue.
Currently, there are three main techniques available which are routinely 
used in various laboratories depending on the requirements to be met.
(a) High pressure liquid chromatographic method (HPLC). Several 
workers have used HPLC in order to separate the catecholamines and their 
respective derivatives (Refshauge et al., 1974; Mell and Gustafson,
1977; Kissinger et al., 1975; Erikson et al., 1977; Hansson et al.,
1978; Imai and Tamura, 1978). With these methods measurement was achieved 
by ultra-violet or fluorometric or electochemical detection. These 
HPLC methods, however, are of only limited sensitivity and cannot be 
used for samples containing relatively low amounts of catecholamines 
(e.g. certain brain areas and urine samples).
(b) Radioenzymatic assay with HPLC. This technique makes use
of COMT and SAM as the methyl donor. The 0-methylated derivatives of 
catecholamine (DA, NA & A) are separated by HPLC. Thus Appel et al.
(1981) reported the determination of catecholamines with radioenzymatic 
assay together with HPLC.
(c) Radioenzymatic assay with TLC. This technique also makes
use of COMT and SAM as the methyl donor, but the 0-methylated derivatives 
are separated by TLC. Basically, (b) and (c) are of equal sensitivity, 
accuracy and specificity and therefore of equal choice. However, HPLC 
separation method is rapid and labour saving as compared to that of
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TLC separation.
In the present study, the radioenzymatic assay of Sailer and Zigmond 
(1978) was set up with certain modifications which will be mentioned 
whenever they are used in the assay. The assay is based on the 
enzymatic conversion of DA, NA and A to their derivatives in the presence 
of COMT using S-adenosyl-L-[methyl-^H]methionine (^H-SAM) as methyl 
donor. Solvent extraction of these derivatives and subsequent separation 
of methoxytyramine (MT), normetanephrine (NMN) and metanephrine (MN) 
was performed using TLC. The basic principle of this assay is diagram— 
matically shown below:
CATECHOLAMINES (DA, N A ,A )  
• OH
COMT, Mg'HO
(DA, NA,A)
SAH
0-METHYLATED DER IVATIVES (MT, NMN, MN) 
3
R.2
CH-CH2-NH 
Ri
(MT, NM N,MN)
COMT, Catechol-O-methyl transferase *  
C H y S A M ,tritiu m  labelled S-adenosyl methionine 
SAH,S-adenosyl homocysteine 
R l- is -H fo r  D A an d M T , -OH for NA, NMN, A and MN 
R2 IS -H fo r  DA,MT, NAand NMN, -CH3  for A and MN
2. Materials and Methods 
3
1000 pi (ImCi) H-SAM (15 curie/mmol) supplied in dilute sulphuric 
acid/ethanol solution (9:1, v/v) was purchased from Amersham Inter­
national, U.K. This solution was divided into 60pl aliquots in order 
to avoid multiple freezing and thawing. The aliquots were stored at 
-20“C (decomposition was minimized when stored under these conditions;
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Amersham International personal communication) until use. Under these
conditions, SAM is stable for several months. Dimethyldichlorosilane,
hydrochloric acid (HCl), magnesium chloride (MgCl2), perchloric acid
(HClo^), ammonium sulphate [(NH^)2S0^], sodium metabisulphate (Na2
820^), di-sodium hydrogen orthophosphate dihydrated (Na2HP0^.2H2O),
sodium di-hydrogen orthophosphate dihydrated (NaH2P0^.2H2O), methanol,
chloroform, toluene and acetic acid (IM), were all purchased from British
Drug House (BDH), Dagenham, and were of Analar grade, dithiothreitol
(DTT), boric acid, pargyline, potassium chloride (KCl), ethyleneglycol-
/
b i s - - a m i n o  ethyl ether) N, N-tetra-acetic acid (EGTA), diethylene 
triamine penta acetic acid (DTPA), L-arterenol bitartrate (L-norepin- 
ephrine bitartrate), epinephrine bitartrate (adrenaline bitartrate), 
3-hydroxytyramine hydrochloride (dopamine hycrochloride), normetanephrine, 
metanephrine, methoxytyramine, tris acetate, tris base (trizma), di- 
(2-ethyl hexyl) phosphoric acid (DEEP), albumin bovine fraction Z (BSA) 
and 70% ethylamine were all obtained from Sigma Chemical Company, U.K. 
and were of highest obtainable grade commercially. 2,5-diphenyloxazole 
(PPG) and 1,4-bis(2-(5-phenyl oxazolyl-benzene (POPOP) were obtained 
from Koch-r-light laboratories, U.K. All the solutions used in the present 
work were prepared with double-distilled water which was prepared by 
2nd distillation of deionized distilled water (see Passon & Peuler,
1973). Silica gel plates (LK6DF, 20 x 20cm, 250pm thickness) were 
used for thin layer chromatography and were obtained from Uniscience 
Ltd., Cambridge. Catechol-o-methyl transferase (COMT) was prepared 
from rat liver, according to the following authors (Axelrod & Tomchick, 
1958; Coyle & Henry, 1973; Cuello, 1979). Dialysis tubing (Visking 
18/32) was obtained from medicell International Ltd., U.K. Glass tubes 
were purchased from Gallenkamp, U.K. Microlitre Hamilton syringes 
were supplied by Howe & Co. Ltd., U.K. Scintillation vial inserts
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(MKII) and vials were obtained from Hughes & Hughes Ltd., Essex, U.K. 
Ultra-violet lamp, model UVSL—58 was supplied by Ultra Violet Products, 
U.S.A.
2.1 Preparation of Catechol-o-methyl transferase (COMT)
COMT was isolated by ammonium sulphate precipitation and the precipitate
Coyle & Henry, 1973) 
(30-45% fraction) collected as crude COMT preparation/. Rat liver was
homogenized in 4 volumes (4ml per Ig of liver) of isotonic KCl (1.19%, 
w/v) and filtered through glass wool in order to remove lipids. The 
filtrate was centrifuged at 78,000g for Ih at 4°C. The resultant pellet 
which contained broken cells and nuclear debris was discarded and the 
supernatant again filtered through glass wool to remove the residual 
lipids. IM acetic acid was added to the supernatant dropwise to bring 
the pH down to 5.3. The preparation was left for 20 min. to equilibrate 
while being kept on ice. It was then spun at 16,000g for 20 min. at 
4°C to separate the precipitate. The supernatant was removed and 
adjusted to pH 6.8 by adding a few drops of freshly prepared 0.5M sodium 
phosphate buffer (pH=7.0). Dry ammonium sulphate, 30% (w/v) saturation 
(16.4g/100ml of supernatant) was added to this supernatant, slowly, 
over a period of 10 min. Then left for Ih while being gently stirred 
on ice. The precipitated protein was removed after centrifugation 
(16,000g for 20 min) at 4°C and discarded. Dry ammonium sulphate 
(8 .6g/100ml supernatant) was added to the supernatant to bring the 
saturation to 45% as described above. After centrifugation (16,000g 
for 20 min) at 4°C the supernatant was discarded and the resulting 
precipitate (30-45% fraction) dissolved in 0.1 volume (0.1ml per 1 
gram of liver weight) of O.IM sodium phosphate buffer (pH=7.0) con­
taining O.lmM DTT. In order to prevent the protein from frothing the 
precipitate was manually dissolved with the help of a sealed pasteur 
pipette. The preparation was then dialyzed overnight against three
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changes of 500 volumes (v/v) of the redissolved 30-45% fraction of (NH^)2 
SO^ precipitate) of the same buffer. This step was taken in order to 
remove (NH^)2S0^ and other small molecules from COMT. The dialyzed 
product was centrifuged (16,000g for 20 min) at 4°C to remove precipit­
ated proteins and the clear supernatant was obtained. Sufficient DTT 
was added to the supernatant to make the final concentration of ImM 
and aliquoted into IOOjjI aliquots and stored at -20°C until use. Under 
these conditions, partially purified enzyme, COMT appears to be stable 
for several months. The specific activity of COMT could be measured 
according to McCaman (1965) by using 3,4 dihydroxy benzoic acid; in 
the present study, however, this was not performed, since it was more 
convenient to compare each enzyme preparation with the previous prepara­
tion in order to determine the optimum volume of the enzyme to be used.
It was found that the activity of the enzyme was consistent from batch 
to batch provided that standard conditions are used as described above.
2.2 Tissue extraction. Extraction of catecholamines and the standard 
assay procedure are shown in a flow sheet (Fig.6). Brain samples taken 
from the MBH and the MPOA (as previously described) were homogenized in 
25jj1 of O.lMHCl containing ImM DTPA and 0.1% (w/v) Na2S20^. Although 
Sallar and Zigmond (1978) used 0.2M HCIO^ as an homogenizing medium 
for the extraction of brain tissues, O.IM HCl was used in the present 
study. It has been shown by Gunne (1963) that the stability of biogenic 
amine, serotonin in perchloric acid extract is poor. Furthermore, 
serotonin was extracted from the brain samples in O.IM HCl instead of 
0.2M HCIO^ (Saavedra, 1977). In the light of these observations,
O.IM HCl was used as a homogenizing medium, throughout l.OmM DTPA was 
included in the homogenizing medium as a general chelating agent in 
order to prevent inference from heavy metal ions
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Fig.6, Diagrammatic summary of the methods of tissue preparation, 
and estimation of catecholamines.
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(e.g. those of Fe, Zn, Cu, Pb, Hg). It was thought that they may be 
introduced into the homogenate from glassware, traces from double­
distilled water or as a contaminant in commercial reagents. Since 
sodium metabisulphite was found to be the most suitable antioxidant, 
this too was added to the homogenizing medium, in 0.1% (w/v) to prevent 
destruction of catecholamines during the homogenization and storage.
O.IM HCl containing ImM DTPA was made as a stock solution and 0.1% 
Na2S20^ was added just before extraction. The tissue was homogenized 
in 25)j1 ice-cold O.IM HCl/DTPA/Na2S20^ by means of a silanized glass 
micro-homogenizer with a right fitted PTF coated stainless steel 
pestle and driven by a dental drill. The homogenate was centrifuged 
at 12,OOOg for 20 min at 4^C, according to Saavedra et al. (1973) 
and the supernatant was transferred in 2 x IOjjI aliquots to silanized
3
2" X /8" glass tubes, capped and stored at -70°C until the catechola­
mines were measured. The remainder (pellet) was saved for protein 
estimation ,. to which 200 /j1 2M NaOH was added, capped, vortex mixed 
and kept at room temperature until analysis. A set of six ’Reagent 
Blank’ tubes per assay containing 10^1 O.IM HCl/DTPA/Na2S20^ but without 
tissue was prepared and great care was taken not to contaminate these 
and other assay tubes. All samples were assayed within 5 days of 
collection.
2.3 Reagents
(3) Standards : Stock solutions of DA, NA and of A were prepared
by dissolving 3.095mg 3-hydroxytyramine hydrochloride, 9.640mg Arternol 
bitartrate and 4.550mg Epinephrine bitartrate, separately, in 100ml, 
of O.OOIM HCl containing ImM DTPA and lOmM DTT. 200j j 1 of these solutions 
were aliquoted and stored at —70°C until use. These standard aliquots 
remained unchanged for three months, the longest time period over which 
they were used. At the time of assay, they were further diluted in
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0.2M HCIO^ containing ImM DTPA and lOmM DTT to give 125pg per lOpl. 
Internal standards were prepared by adding 125pg of each standard to 
one of the IOjjI aliquots of the tissue extract (previously described) 
and the external standards were prepared by adding 125pg to lOpl 
O.IM HCl/DTPA/NazSzO^.
(b) Buffers ;
(i) 2M Tris acetate buffer (pH=8.8)
2MTris acetate and 2M Tris base were mixed in an approx­
imate ratio of 1:2 to give a final pH of 8.8, adjusted if necessary
(ii) 0.5M Sodium borate buffer (pH=9.0)
0.5M Boric acid and 0.5M Potassium chloride were added 
to 500ml double distilled water and gently warmed until dissolved.
The pH was adjusted to 9.0 by adding IM NaOH and further diluted to
1.0 litre.
(iii) 0.4M Sodium borate buffer (pH=11.0)
0.4M Boric acid 0.4M Potassium chloride were added and 
the pH adjusted to 11.0 as described above.
(c) 0.2M HCIO,:--------- 4
This was prepared by diluting 2.139ml of 60-62% HCIO^ to 100ml 
with double distilled water.
(c) MgCl2Solution (40mM)
This was made by adding 52mg MgCl2.6H20 in 1.0ml of 0.2M HCIO^ 
to give a find concentration of 40mM when added to 5j j 1 in the assay 
tube.
(e) Phosphotungstic acid solution [*PTA’, 1% (w/v]
1% (w/v) PTA was made by dissolving Ig in 100ml of 0.5M HCl.
(f) Dithiothreitol Solution [’DTTl, (lOmM)]
This was made up fresh when required by adding 15.4mg of DTT 
per 10ml of 0.2M HCl0^ containing ImM DTPA.
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(g) Scintillation fluid:
4g of PPO and 50mg of POPOP were added to 1 litre of toluene 
and to this 25ml of DEHP (2.5%, v/v) was added. The solution was allowed 
to mix on a mechanical stirrer for >5hr and 5ml per scintillation vial 
was routinely used.
(h) Homogenizing medium (o.lM HCl/ImM DTPA/0.l2%w/v)Na2S20r:
This was prepared by diluting 2M HCl to O.IM, to which ImM diethy­
lene triamine penta acetic acid (39.34mg/100ml) was added. To this 
stock solution 0.1% (w/v) sodium metabisulphite (Img/ml) was added 
freshly when required to use.
(i) Thin-layer chromatographic solvent
This was made from chloroform:methanol: 70% ethylamine:: 16:3:2
(v/v/v).
2.4 Standard assay procedure
Each assay included:
(i) Six ’reagent blank’ tubes;
These were prepared by omitting catecholamines and the tissue 
extract. This was a modification of SSllar & Zigmond’s assay in which 
’tissue blanks’ were prepared by adding 0.2M HCIO^ containing CaCl2*
2H2O (40mM) in place of MgCl2 to the lOgl tissue extract in order to 
inhibit COMT reaction. However, ’reagent blanks’ were identical to 
that of ’tissue blanks’ and therefore were routinely used for each 
assay. Blanks prepared in this way are in agreement with an earlier 
report of Passon & Peuler (1973) in which noradrenaline and adrenaline 
were measured by a radioenzymatic assay.
(ii) Unknown samples of tissue extract;
2 X 10^1 aliquots of either MPOA or MBH supernatants [described 
previously] were run in parallel.
(iii) Internal standard tubes;
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To one of the 2 x lOpl aliquots of the supernatant, [see 
the sub-section (2.2) on tissue extraction in this section *C’] 125pg 
of each DA, NA and A standard was added. This amount of standard was 
chosen since it was within the range of the standard curve for DA,
NA and A (Fig.7). The standard curve was obtained by preparing a set 
of tubes containing lOpl of the MBH tissue extract pool (10 MBH punches/ 
250pl homogenizing medium) and to some of these tubes various amounts 
of catecholamines were added. The tissue and tissue containing catechol­
amines were run in parallel. The addition of standards to the tissue 
serves two purposes:
(a) it acts as a marker to indicate a satisfactory measurement 
of the known amount of DA, NA and A in the presence of tissue extract
(b) since the other portion of 2 x lOjjl supernatant extract contains 
the same amount of supernatant but without the addition of DA, NA,
A standard, the counts per minute (CPM) obtained were matched with 
the internal standard tube and subtracted from it [Internal standards 
+ lOpl tissue extract (CPM) - lOpl tissue extract (CPM) = Internal 
standard (CPM) and the absolute CPM thus obtained corresponding to 
T25pg of each standard (DA, NA, A) was used in calculating the unknown 
amount of DA, NA and A.
(iv) External standards;
A set of six tubes was prepared by the addition of IOjjI 
O.IM HCl/ImM DTPA/0.1% Na2S20^[homogenizing medium] and 125pg of each 
DA, NA and A, but devoid of tissue extract. The CPM obtained from 
these tubes matched very well with the absolute CPM corresponding to 
DA, NA and A [as described above]. It is assumed therefore, that there 
was no interference, whatsoever, caused by the tissue extract.
On the day of assay, the following solutions and reagents
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Fig.7. Relationship of DA, NA and A concentrations to radioactivity 
(CPM) as determined by radioenzymatic assay.
Each point is the average of 3 individual results after correction 
for the IOjjI tissue extract.
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were made up freshly.
(i) To the stock solution of 0.2M HCIO^ containing ImM DTPA, was 
added DTT (15.4mg per 10ml).
(ii) Preparation of BSA/DTT/Pargyline solution:
The following chemicals were weighed out -
(a) 6mg BSA and 23mg DTT in a plastic tube (PT0944)
(b) 7.8mg pargyline,per ml double distilled water,in a PT0944
tube.
BSA/DTT/Pargyline solution was made by mixing 1.0ml of (b)
to (a). Since this solution precipitates out if kept on ice, (b) to
(a) was added when needed for the enzymatic reaction mixture. Ipl 
per each assay tube was added to the reaction mixture. This gave a 
final concentration of BSA, DTT and Pargyline as 0.18% (w/v), 50mM 
and 1.25mM respectively [as described by Sailer & Zigmond, 1978].
(iii) Preparation of EGTA/Tris-acetate buffer
7.6mg of EGTA was weighed out in a PT0944 tube and to this 
1ml Tris—acetate buffer [pH=8.8] was added, corresponding to a final 
concentration of 5mM EGTA and 500mM Tris-acetate buffer [pH=8.8] when 
8pl of this solution was added to the assay tube.
The addition of BSA, DTT, Parglynine and EGTA in the assay 
tubes prior to incubation is essential since it serves two purposes:
(a) keeps COMT in an active form
(b) minimises the errors involved in the estimation of
catecholamines.
Read et al. (1970) found that a large dilution of enzymes can poss­
ibly inactivate them. The problem can be minimised by addition of BSA 
at a final concentration of approx. 0.1-1% (w/v). Similarly, the 
oxidation of thiol groups of enzymes can cause inactivation (Cleland,
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1964). The enzymes are inhibited due to conversion of SH groups into-
s-s-groups. This problem can be overcome by inclusion of DTT. McCaman
et al., (1965) found that the COMT preparation is not entirely pure in
that it contains a small amount of monoamine oxidase (MAO) activity.
The presence of this enzyme (MAO) in the assay might interfere with 0-
methylation of catecholamines. However, this problem can be overcome by
inclusion of an inhibitor of MAO e.g. Pargyline. Zammit & Newsholme,
2+
1976, found that Ca concentration can be minimized in a solution by
2+
the addition of EGTA which is more specific for Ca than other chelating
2+
agents. It is therefore important to use EGTA when Mg is essential for 
the activity of COMT.
(iv) Dilution of standards:
One aliquot of each of the DA, NA and A concentrated standards 
were thawed and kept on ice. lOpl of each of the DA, NA and A aliquots 
was added to 9.990ml HCIO^/DTPA/DTT solution, mixed briefly and kept on 
ice until used.
(v) Carrier solution:
This was made by dissolving Img per ml of each 3-methoxytyramine, 
noremetanephrine and metanephrine in 0.1% (w/v) Na2S20^ and kept at 4°C 
until used.
(vi) Reagent I:
was made by mixing equal volumes of 0.2M HCIO^/DTPA/DTT and 
MgCl2 solutions corresponding to 5jj1 of each solution per assay tube and 
depending on the number of total blanks and tissue tubes to be assayed.
(vii) Reagent II:
was made by mixing equal volumes of 0.2M HCIO^/DTPA/DTT 
containing 125g of DA, NA, A and MgCl2Solution, corresponding to 5pl
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of each solution per assay tube and depending on the total number of 
internal and external standard tubes,
(viii) Preparation of the enzymatic Reaction mixture:
This was made by mixing 8pl EGTA/tris-acetate buffer, Ipl
BSA/DTT/Pargyline, 4,5jj1 COMT (optimum volume) and l,5pl of S-adenosyl
3
[methyl- H] methionine [1.5jjCi]; per assay tube. All the above amounts 
were multiplied by the number of total tubes and then added in that 
proportion, mixed gently (avoiding frothing) and kept on ice until 
used.
A. All the assay tubes were kept on ice -
(a) lOpl of reagent I was added to each of the ’Reagent blank*
and tissue tubes.
(b) lOpl of Reagent II was added to internal and external standard 
tubes.
B. 15/j1 of the enzymatic reaction mixture was added to each tube 
and immediately vortex-mixed briefly. The addition of reagents and 
enzymatic mixture to all tubes was done within 10 min. to ensure that 
all the components of reaction remained stable (see Sailer & Zigmond, 
1978).
C. The reaction was initiated by placing these tubes into a shaking 
water bath at 30°C.
D. The reaction was terminated after 30 min. by placing them in an 
ice bath and adding 250pl 1% PTA (preparation described) and briefly 
vortex-mixed.
E. These were centrifuged on Mistral 6L at 15,00g for 30 min. at 
10°C. Although Sallar & Zigmond (1978) used lOpl 20% (w/v) PTA, in 
the present method 250pl of 1% PTA was used since a preliminary study
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showed that this amount of PTA in 0.5M HCl when added to the tubes 
gave a much better sample to blank ratio.
F. 200pl of the supernatant was transferred to silanized round-bottomed 
10 X 1.5cm glass tubes containing 1ml 0.4M borate buffer (pH=ll): carrier 
solution (20:1, v/v). 3ml of toluene/isoamyl alcohol (3:2, v/v) was 
then added to these tubes, vortex-mixed for 30 seconds and centrifuged
at 15,00g for 10 min. at 10°C.
G. 2.4ml of the organic phase was transferred to silanized conical 
pointed glass tubes (10 x 1.5cm) containing 50j j1 O.IM HCl/lmM DTPA/0.1% 
Na2S20^ vortex-mixed for 30s and centrifuged at 15,00g for 10 min. at 10°C,
H. The organic phase was aspirated and 40pl of the acid phase was 
transferred to LP2 tube. This was either applied to the TLC plates 
or capped and stored overnight at -20°C until required. This method 
of toluene/isoamyl alcohol extraction followed by re-extraction into 
O.IM H d  is in accordance with Cuello's (1979) method, however, some 
minor modifications were made. It was found that the method of solvent 
extraction was necessary to reduce the radioactivity of the blank values 
and thus, to increase the sensitivity of the assay. This has been
used throughout the present study.
2.5 Thin-layer Chromatography:
LK6DF TLC plates were sprayed with an antioxidant, 0.1% (w/v) DTT solution 
in absolute alcohol and left in a fume cupboard for 30 min. at room 
temperature for drying. 5jj1 of the carrier solution (see V of the 
standard assay procedure of this chapter) was applied to each channel 
of the TLC plate with a Hamilton syringe. This was followed by addition 
of 30pl of the acid phase (see ’H' of the standard assay procedure) 
to the same channels. A set of ’reagent blank’ matching ’tissue’ and 
’internal standards’, and external standards were applied to the same
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TLC plate in order to avoid any possible variation involved in the inter- 
TLC plate developing procedure. The plates were dried in a fume cupboard 
for 30min. at room temperature and then developed for 90 min. in a 
chromatographic tank containing chloroform/methanol/ethylamine (16:3:2) 
in the dark. The developed plate was then dried in a fume cupboard 
for 10 min. at room temperature and the ’spots' .corresponding to methoxy- 
tyramine (MT), normetanephrine (MN) and metanephrine (M) were visualized 
under U.V. light (254 nm) . A preliminary study was performed in which 
authentic MT, MN and M were applied to TLC plates and this confirmed 
the separation and location of the spots which is in agreement with 
the Rf values [the distance travelled by a methoxyderivative spot divided 
by the distance travelled by the solvent front for MT, NM and M, as 
reported by Sailer and Zigmond (1978). The areas corresponding to 
MT, NM and M were scraped off the plate and transferred to scintillation 
vial inserts containing 0.1ml borate buffer (pH=10). 5ml of scintillation 
fluid containing 2.5% (v/v) DEEP was subsequently added and vortex-mixed 
for 30s. The inserts were put into scintillation vials and counted on 
a Packard ^-counter for 10 min. each after keeping the vials at room 
temperature for >lhr. Although Sailer and Zigmond have reported the 
use of 5ml of Econofluor [pre-mixed scintillation fluid], however, 
the performance characteristics of the present toluene base scintillant 
[preparation described] are similar to Econofluor [NEN Chemicals, U.S.A]. 
This is reflected by the similar tritium efficiencies (i.e. Econofluor 
efficiency, approx. 56%; present scintillation fluid, approx. 53%
(Table 1).
2.6 Counting Efficiency. The counting efficiency of Packard ^ -counter 
for tritium was determined by the ’internal standard method’. In this
3
method 25pl of [ H]-toluene containing 500 disintegration per minute 
(ADPM) were added to the various samples of MT, NM and M obtained after
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radioenzymatic and TLC steps as described in this chapter. These were
recounted and the counting efficiency was calculated as shown below;-
A sample [MT, NM, M] of unknown disintegration per minute (DPM) was
counted on the j$-counter and this gave a certain number of counts per
minute (CPM ’C ’) [e.g. metanephrine (M) CPM(C) = 200]. This was then
recounted (total CPM = C + A C  or AC  = total CPM -C; total CPM = 450
and AC = 250) after the addition of a  DPM and therefore 250 CPM ( a C)
corresponds to the added ADPM. The counting efficiency (E) (%) = _^5_ xlOO
A  DPM
250
.*. E = X 100 = 50%
500
The efficiency was consistent from sample to sample as indicated by low
S.E.M. (Table 1). This was expected because all the samples were of
the same composition with respect to any quenching agent present.
This method of internal standardization was adopted initially, but its
continuous use was not feasible. Instead the ’external standard channel
ratio’ method was routinely used. The ratio of counts obtained in two
separate high and low energy channels in response to gamma-rays emitted
137
by a radiation source [ Cs] external to the counting vial but contained
3
within the instrument was related to the [ H]-efficiency of 53% [calcu­
lated by the ’internal standard’ method]. This method is especially 
useful if the activity of the sample is too low to use the ’channel ratio’ 
method. Consistent external standard channel ratio values wereobtained 
and therefore counting efficiency does not vary from sample to sample.
3
Table No.l. Counting efficiency (E) of tritium ( H) added to the final 
liquid scintillation mixture
2Ï C
Fraction E(%) = --------  x 100
A D P M
(Mean ± S.E.M., n = 5)
Methoxytyramine 53.4 ± 2.6
Normetanephrine 53.0 ± 1.3
Metanephrine 51.5 ± 2.0
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2.7 Calculations :
DA, NA & A concentrations present in tissue specimens were determined 
using a pre-programmed computer [Apple II]. The determination was performed 
by evaluating radioactivity (CPM) present in the Veagent blank’, ’tissue’ 
and ’internal standard’ samples. Internal standard and unknown samples 
(’tissue’) were then corrected for ’tissue’ (CPM) and ’reagent blanks’ 
resepctively. Corrected CPM for unknowns were compared to those of 125pg 
pure standards. However, ’A ’ CPM were further corrected for cross­
contamination of DA (0.7%) and NA (0.46%) (see Sailer & Zigmond, 1978) 
before comparison to those of 125pg ’A ’ standard. Since linearity of 
the standard curve (Fig.7) was proven for at least up to 250pg which lies 
well within the range of the maximum levels measured in any sample, 
quantification could be made by means of a calibration factor (absolute 
CPM for standards).
2.8 Reliability Criteria:
Precision is estimated from the coefficients of variation as discussed 
in the section ’A ’ of this chapter.
(a) Inter-assay coefficient of variation for adrenaline:
Mean Standard deviation Coefficient of
(CPM) variation
1221 127.66 10.45%
n = 7
(b) Intra-assay coefficient of variation:
Mean Standard deviation Coefficient of
(CPM) variation
1283 48.40 3.77%
n = 10
2.9 Sensitivity & Specificity:
The sensitivity (2 x S.D. of the reagent blanks) resulted in 
DA = 8.0pg, NA = 11.5, A = 7.5pg
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These were considered to be the smallest amount of catecholamines which 
could be reliably measured and values lower than these were designated 
non-detectable (ND). Although the sensitivity of the assay can be
3
increased by using [ H]-SA.M of much higher specific activity. Never­
theless, SAM (15Ci/mmol) was found to be both adequate and economical 
since the sensitivities obtained were consistant with reliable measurements 
of catecholamine concentration in discrete areas of the brain.
This assay is considered to be highly specific for each of the catechola­
mines. This is due to its specificity derived at three different steps:
(a) the enzyme, COMT is specific for catechols regardless of substituent 
on the aromatic ring, however, monophenols are not methylated by COMT 
(Axelrod and Tomchick, 1958).
(b) the extraction of COMT products into toluene-isoamyl alcohol (see Fig.
6 in this chapter) from borate buffer (pH 10; final pH of the mixture) 
occurs most readily with o-methylated catechols but not with catechols 
(Axelrod, 1962).
(c) the TLC step appears to separate o-methylated catechols on the basis of 
polarity of their side chains. Although specificity of the assay can be 
assumed to be excellent due to enzymatic labelling with subsequent TLC 
separation, however there was little cross contamination between the 
catecholamines. It was found that 0.70% DA CPM and 0.46% NA CPM - cross 
contaminated - A CPM, therefore corrections were made, by subtracting
0.70% DA CPM and 0.46% NA CPM from ’A ’ CPM, in the calculations.
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SECTION ’D'
RADIOMETRIC ASSAY OF PHENYLETHMOLAMINE-N-METHYL TRANSFERASE
1. Introduction
The conversion of noradrenaline (NA) to adrenaline (A) is the final step 
in catecholamine biosynthesis (Blaschko, 1939). Phenylethanolamine-N- 
methyl transferase (PNMT), EC2.1.1.28)is the enzyme which catalyzes 
this reaction. The reaction involves N-methylation of NA to A in the 
presence of S-adenosyl methionine (SAM) as the methyl donor.
The enzyme was first reported by Kirshner and Goodall in 1957, to be 
present in the soluble fraction of homogenates of bovine adrenal medulla. 
The enzyme is also known more conveniently as noradrenaline-N-methyl 
transferase (NMT; Fuller & Hemrich-Luecke, 1983). However, the enzyme 
exhibits only slight specificity for the substituents attached to the 
aromatic ring, but a hydroxyl group at the p-position of the side chain 
of a variety of phenylethylamines is an essential requirement (Marki et 
al., 1962). In the present work the commonest name, phenylethanolamine- 
N-methyl transferase (PNMT), was adopted and in general the reaction 
catalyzed is as follows:
fi -hydroxyphenylethylamine N-methylated ^ -hydroxy
_______ phenylethylamine
+ ^  +
S-adenosyl methionine S-adenosyl homocysteine
A great deal of work has been done on adrenal PNMT, in order to establish
the enzyme properties. Thus Axelrod (1962) first reported the purifica­
tion and properties of PNMT isolated from monkey adrenals, and showed
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that maximum activity occurred from pH7.5 to 8.2 in 0.IMphosphate 
buffer and 8.0 to 9.0 in O.IM tris buffer using normetanephrine as a 
substrate and SAM the methyl donor. The Michaelis-Menten constant 
[defined as the substrate concentration at which enzyme velocity is 
half maximal] for N-methylation of normetanephrine was found to be
5 X 10 ^^M. Furthermore, this author discovered that the enzyme activity 
was almost completely inhibited with p-chloromercurLbenzoate indicating 
the presence of essential sulfhydryl groups. With respect to substrate 
specificity, it was found that the ^ -hydroxylated phenlethylamines
and their derivatives are methylated, but not phenylethylamine. Connet 
and Kirshner (1970), studied the purification and properties of bovine 
adrenal PNMT and have, shown that the enzyme contains sulfhydryls which 
is in agreement with that of Axelrod (1962). However, the optimum pH 
in both O.IM phosphate and borate buffers is very precise, 7.9 in contrast 
to Axelrod’s results. The molecular weight determined by these authors 
as assessed from the calibration curve established by the elution of 
marker proteins, for PNMT (mono-meric protein) is 38,000 which is identical 
to that obtained for rat adrenals (Yu, 1978). However, the optimum 
pH is different from that of Yu’s results, since this author found it 
to be 9.0 in either tris or phosphate buffer. Species difference might 
be the reason for differences in the pH optimum. Furthermore, Connet
6 Kirshner found the presence of only one form of PNMT in bovine adrenals 
and the absence of isoenzymes; the enzyme was found to be stable for at 
least 50min. at 39°C, but rapidly destroyed at 45°C.
Brain pheylethanolamine-N-methyl transferase
Although phenylethanolamine-N-methyl transferase was originally identified 
in adrenal medulla, a similar enzyme in low concentration has been found 
in the mammalian central nervous system (CNS). Thus, Axelrod (1962) 
indicated that minute amounts are present in the midbrain area
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of the rabbit . McGeer and McGeer (1964) also indicated its presence
3
by observing that a small fraction o f [ H]-noradrenaline injected directly
3
into monkey or cat brainstem and caudate could be recovered as [ H]- 
adrenaline. In the past years, its presence in mammalian CNS has been 
well established (Ciaranello et al., 1969; Pohorecky et al., 1969;
Hôkfelt et al., 1973; Saavedra et al., 1974b;Chalmer et al., 1981 and 
Fuller et al., 1982) and Yu (1978) has reported its comparison with 
adrenal PNMT. According to Yu (1978), PNMT isolated from the rat brain 
possesses some physiochemical properties which are different from that 
of PNMT isolated from the adrenal medulla. The differences are:
(1) the brain PNMT molecular weight is 25,000 whereas the adrenal PNMT
38,000 identical to that obtained for bovine adrenals (Cdnnett and 
Kirshner, 1970); (2) the pH optima in phosphate and tris buffers was
found to be 9.0 and 7.8 for the partially purified rat adrenal and 
brain PNMT respectively; (3) the Michaelis-Menten constant (Km) for 
^-hydroxylated phenylethylamines indicated that the brain PNMT was 
higher than that of adrenal PNMT. Perhaps the low ratio of adrenaline 
to noradrenaline (1:10) [Mefford et al., 1977; Koslow and Schlumpf 
1974; Gunne, 1962; Vogt, 1954] is a consequence of the low activity 
of the brain PNMT due to high Km value. The optimum pH of 7.9 for 
brain PNMT is in agreement with the results of Ciaranello et al., (1969) 
and Pendleton et al., (1977), but different from that of Saavedra et 
al., (1974b)who found it to be 8.6.
Non-specific N-methylation in the brain
In addition to PNMT (solubleprotein, present in the cytosol) there 
is another soluble protein or family of proteins present in the cytosol 
known as non-specific N-methyl transferase. The presence of this protein 
in the brain was reported by Saavedra et al., (1973). This enzyme 
N-methylatès : a large number of substrates, tryptamine,^-hydroxylated
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phenylethylamine, phenylethylamine etc., and exhibits pH of 7.9, similar 
to brain PNMT (Pendleton et al., 1977). The non-specific activity 
was found to be highest in the cerebral cortex and striatum and lowest 
in the medulla-pons and olfactory lobe of the rat brain. Similarly, 
Pendleton et al., (1977) have reported a regional distribution of non­
specific N-methyl transferase activity. The spinal cord, brain stem 
and cerebellum had negligible activities, but significantly higher in 
the midbrain and forebrain of the rat.
In the light of the above survey of previous work on pheylethanolamine- 
N-methyl transferase in the brain and the adrenal medulla, it is clear 
that discrepancies exist with regard to the optimum pH. Since the 
main objective was to establish a highly sensitive and specific assay 
so that PNMT activity present in the discrete areas of the hypothalamus 
could be measured, the characteristics of PNMT were studied in detail.
2. PNMT Assay
A review of the literature concerning PNMT revealed that various authors 
have measured PNMT activity by a basic radioisotopic method with certain 
modifications (Axelrod, 1962; Pohorecky et al., 1969; Connet and Kirshner, 
1970; Saavedra et al., 1974b Pendleton et al., 1977; Howe et al., 1981; 
Fuller et al., 1982). In the present study PNMT activity was measured 
by a modification of the method previously described by Pendleton et 
al., (1977). The basic principle of this assay is shown in Fig.8.
3. Materials and Methods
Details of the suppliers for most of the reagents used in this assay 
are described in the section on radioenzymatic assay of catecholamines, 
however, the remainder are mentioned here.
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Fig.8. Diagrammatic representation of the basic principle of 
phenylethanolamine-N-methyl transferase (PNMT) assay, methods of 
tissue preparation, and estimation of PNMT activity.
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3.1 Reagents
(a) Homogenizing medium: 1.19% (w/v) KCl containing 0.5mM DTT,
1.19% KCl - 1.19g/100ml double distilled water
0.5mM DTT - 0.385mg DTT [made fresh] 4mg DTT was 
dissolved in 500jj1 1.19% KCl - 48jj1 of this solution was diluted in 
5ml with 1.19% KCl.
Pendleton et al., (1977) homogenized brain tissue in 1.5 volumes (w/v) 
of isotonic (1.19%) KCl without DTT.
Since a survey of the literature indicated that PNMT contains sulfhydryl 
groups, which are essential for maximum activity, a recommended amount 
of DTT was also included in the homogenizing medium and 10 volumes 
instead of 1.5 volumes was found to be more convenient for homogenizing 
brain tissue.
(b) Buffers:
Tris-HCl buffer, 0.2M, pH= 8.8
(1) 0.4 M HCl
(2) 0.4 M trirs base
(1) was added to (2) until pH reached 8.8 and then diluted 
to 200mls with double distilled water.
Sodium borate buffer, 0.5M, pH = 10
30.92g boric acid and 37.28g potassium chloride were added 
to 500mls double distilled water (slight warming is necessary), then 
added IM NaOH until pH reached 10 and then diluted it to 1 litre.
(c) ^-Hydroxyphenylethylamine solution (BHPEA, 20mM)
[13.78mg/5ml double distilled water]
The stock solution of BHPEA kept well at 4°C for at least 
two weeks [the maximum time for which one preparation of the stock 
solution was routinely used]. BHPEA was supplied by Sigma Chemical 
Company, U.K.
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(d) Phenylethylamine and tryptamine solutions
Each of these solutions was prepared to give a final concen- 
*“3
tration at 1.6 x 10 M in the incubation medium which is similar to 
that described by Saavedra et al., (1973),
(e) Toluene-isoamyl alcohol mixture (97:3, v/v)
(f) O.lMHClwas kept as stock solution at 4°C for several months
(g) Scintillation fluid (ACS II)
Aqueous containing scintillation fluid supplied by Amersham 
International was routinely used and gave an efficiency of 50% for 
tritium [Amersham International personal communication].
3.2 Tissue extraction
(a) Characteristics of PNMT were studied using the whole hypothalamic 
crude extract of pheitylethanolamine-N-methyl transferase and this was 
prepared by homogenizing 4 - 8  hypothalami.
Albino Wistar male adult rats were stunned and rapidly decapitated 
with large scissors. The brain was removed immediately and placed 
ventral side uppermost on ice-cooled metal plate. The hypothalamus 
(an area of the diencephalon, lying at the base of the brain, ventral 
to the thalamus, and forming the floor and part of the lateral walls 
of the third ventricle) was dissected along neuroanatomic boundaries.
A coronal cut was made rostrally through the optic chiasma and caudally 
through the mammilary bodies and then laterally through each lateral 
ventricles. The isolated hypothalamus was, imemdiately transferred 
to a metal plate on solid CO2 (dry ice). The hypohtalami were weighed 
quickly using a micro-balance [Mettler, AE163, Mettler Instrument 
Switzerland] and then homogenized in ice-cold lOvol (w/v) (Saavedra 
et al., 1974b) homogenizing medium (1.19% KC1/0.5M DTT), (Pendleton 
et al., (1977). The homogenate was transferred to ice-cold centrifuge 
tubes and spun at 20,000g for 30min at 4°C (Fig.8). The supernatant
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was transferred to silanized glass tubes, capped and kept at -70°C 
until assayed. To the remaining pellet 2M NaOH [200pl per mg wet weight 
of the hypothalamus] was added, mixed, and then capped and left at 
room temperature until assayed for protein content.
(b) The MPOA and MBH samples
Samples from the MPOA and MBH were obtained as described prev­
iously (see Section ’B ’ in this chapter). They were homogenized in 
60pl homogenizing medium and then transferred to ice-cold LP2 tubes.
The tubes were spun at 20,000g. The supernatant was transferred in 
2 X 25pl aliquots to silanized 3” x Y' glass tubes, capped and kept 
at -70°C until assayed. 200pl 2M NaOH was added to the remaining pellet 
and the tubes were mixed briefly, capped and kept at room temperature 
before being assayed for their protein content (see Appendix for 
the protein assay details).
3.3 Characteristics of pheylethanolamine-N-methyl transferase;
It is well established that a variation of enzyme activity takes place 
as a result of a change in temperature (see for example Alp et al.,
1976; Arch and Newsholme, 1976). However, the effect of temperature 
on PNMT activity was not explored in the present studies since the 
preferred temperature (37°C) at which physiologically meaningful results 
are to be obtained, has been frequently used by other authors who have 
reported measurements of PNMT activity (Saavedra et al.,1974b; Pendleton 
et al., 1977; Yu, 1978).
(a) Effect of pH on the specific activity of PNMT [N-methylation 
of ^-hydroxyphenylethylamine (BHPEA), pmol/h/mg];
50pl of the rat hypothalamic supernatant (the preparation of which 
has already been described in section 3.2 of this chapter) was incubated
3
at 37°C for 60min with 80pl BHPEA, 0.54pmol of [ H]-methyl-S-adenosyl 
methionine (specific activity, 15Ci/mmol) (see Saavedra et al., 1974b;
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Pendleton et al., 1977) and Spmol of tris buffer at varying pH (7.4,
7.9, 8.4, 8.9 and 9.2) in a final volume of 150pl. PNMT specific activity 
was plotted against pH and a bell-shaped curve was obtained and the 
optimum pH being 8.85 as shown by the arrow (Fig.9). This contrasts 
with studies by Pendleton et al., (1977) in which phosphate buffer 
of pH7.9 was used in order to measure rat brain PNMT activity. However, 
the optimum pH obtained in the present study was commensurate with 
that pH used by Saavedra et al., (1974b)for the measurement of PNMT 
activity in rat brain nuclei.
(b) Effect of concentration of BHPEA on the specific activity 
of PNMT (N-methylation of BHPEA; pmol/h/mg);
50pl of rat hypothalamic supernatant was incubated at 37°C for 60min 
with 80pl of a solution containing 5pmol of tris buffer (pH 8.8), 0.54 
nmol of [ H]-methyl-s-adenosyl methionine and 20pl of a solution con­
taining varying amounts of BHPEA (45, 120, 195, 255 and 360 nmol) in 
a final volume of 150pl. The amount of BHPEA required in order to 
get an optimum PNMT activity is shown by the arrow in the hyperbolic 
curve (Fig.10; BHPEA concn.240nmol/150pl or 1.60mM). This amount of 
BHPEA required to obtain optimum conditions is in agreement with data
previously published by Pendleton et al., (1977).
3  .
(c) Effect of Ç-H]-methyl-s-adenosyl methionine on the specific 
activity of PNMT:
50pl of rat hypothalamic supernatant was indubated at 37°C for 60min 
with a solution of lOOpl containing 5pmol tris buffer (pH 8.8), 240nmol 
of BHPEA and various amounts (37.5, 75, 150, 300, 450, and 600 pmol)
3
of [ H]-methyl-s-adenosyl methionine. The volume changes caused by 
3
the addition of [ H]-SAM were negligible. The optimum concentrations 
of SAM required to obtain maximum PNMT activity is shown by the arrow 
(Fig.11; optimum concentration of SAM, 450pmol/150pl or 3pM). This
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Fig.9. Effect of varying pH on the specific activity of pheny­
lethanolamine-N-methyl transferase (PNMT). The standard assay pH 
(8.85) is indicated by the arrow.
Each point is a mean of 3 determinations.
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Fig.10. Effect of varying the concentration of ^ — hydroxyphenyl- 
ethylamine (BHPEA) on the specific activity of phenylethanolamine- 
N-methyl transferase (PNMT). The standard assay concentration of 
total BHPEA (1.60mM) is indicated by the arrow.
Each point is a mean of 3 determinations.
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Fig.11. Effect of varying the concentration of S-adenosyl-(methy1-
3
H) methionine (SAM) on the specific activity of phenylethanolamine- 
N-methyl transferase (PNMT). The standard assay concentration of 
total SAM (3pm) is indicated by the arrow.
Each point is a mean of 2 determinations.
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concentration is similar to that reported by Saavedra et al., (1974b)
3
since they used 3.5pM concentration of [ HJ-SAM. However, labelled 
SAM supplied by Amersham International had a specific activity of 15 
Ci/mmol whereas Saavedra et al (1974b) used 4.5 Ci/mmol of labelled 
SAM in order to measure PNMT activity in brain nuclei. Consequently, 
it was worthwhile making an attempt to cut down the amount of labelled 
SAM and replace it with an equal amount of unlabelled SAM. This worked 
well and subsequently a mixture of labelled and unlabelled SAM were 
used.
(d) Specific and non-specific PNMT activity:
50pl of rat hypothalamic supernatant was incubated at 37°C for 60min 
with a lOOpl solution containing 5qmol of tris buffer (pH 8.8), either 
240 nmol of BHPEA and 240 nmol of tryptamine or 240 nmol of pheylethyl- 
amine (PEA) and 450 pmol of SAM (225pmol of labelled SAM and 225 pmol 
of unlabelled SAM) . The histograms of specific and non-specific activity 
indicate that a negligible amount of non-specific activity was present 
when measured by this assay (Fig.12). This suggests that the present 
radiometric assay is highly specific. However, Pendleton et al., (1977), 
have reported much higher non-specific activities in a combined section 
of rat brain mesencephalon and diencephalon. The difference might be 
accounted for by the non-specific activity present in the mesencephalon 
or due to the different pH of the enzymatic reaction mixture since 
they used a buffer of pH 7.9. It is possible that non-specific methyl 
transferase is more active at pH 7.9 than 8.8.
(e) Effect of time of incubation on the PNMT reaction product 
(Pmol/mg)
50pl of the rat hypothalamic supernatant was incubated at 37°C for 
various times (15, 30, 45, 60 and 75min) with a lOOpl solution containing 
5pmol tris buffer (pH 8.8), 240nmol of BHPEA and 450 pmol labelled
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Fig.12. Specific and non-specific activities present in the pooled 
rat hypothalamic supernatant. Portions of the supernatant 
were incubated with either phenylethanolamine ( j j ü S É  ) 
phenylethylamine ( ) or tryptamine ( ) as
described in the text.
Each bar represents mean ± S.E.M. of 4 separate pooled 
hypothalamic supernatants.
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Fig.13. Effect of varying the incubation time on the formation of 
N-methyl phenylethanolamine. The standard assay incubation time is 
indicated by the arrow.
Each point is a mean of 3 determinations.
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and unlabelled SAM. The plot of the PNMT reaction product versus time 
of incubation gave a linear curve (Fig.13). One hour of incubation 
was found to be optimum for PNMT assay conditions. This is in agree­
ment with the previous studies by both Saavedra et al., (1974b) and 
Pendleton et al., (1977).
(f) Effect of varying the volume of hypothalamic supernatant on 
the PNMT activity:
lOOjjl of a solution containing 5jjmol tris buffer (pH 8.8), 240nmol 
BHPEA and 225pmol of each labelled and unlabelled SAM was incubated 
with various amounts of rat hypothalamic supernatant (2.5, 5, 10, 20,
30 and 50jj1) in a final volume of 150jj1.
Since the range of protein present in the brain punches for which this 
assay was ultimately used (protein range shown by the hatched area.
Fig.14) lies well within the linear curve of the relationship between 
PNMT activity and the hypothalamic supernatant. Therefore, this observa­
tion justifies the validity of this assay.
3.4 Standard assay procedure
Each assay included three sets of tubes:
(a) ’Tissue blanks';were prepared by adding pheylethylamine in 
place of P-hydroxypheylethylamine (Phenylethanolamine) to one of the 
2 X 25jj1 aliquots of the PNMT extract. However, it was found that 
exactly the same blank values were obtained by omitting phenylethylamine, 
Therefore, subsequent blanks were prepared by adding all the reagents
in the same proportion except for -hydroxyIphenylethylamine.
(b) ’Unknown samples'; to the other portion (2 x 25jj1 aliquots), 
all reagents and ^-hydroxyphenylethylamine were added and run within 
the same assay including 'tissue blank'.
(c) 'External standard tubes'; a set of eight tubes was prepared 
by the addition of all the reagents in the unknown samples and in the
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Fig.14. Effect of varying the hypothalamic supernatant (which 
contains protein) on phenylethanolamine-N-methyl transferase (PNMT) 
activity.
The protein range (0.02 - 0.04mg) in the supernatant of the standard 
assay for brain punches is indicated by the hatched area.
Each point is a mean of 3 determinations.
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same proportion. However, the omission of the tissue extract and the 
inclusion of two separate standards prepared by redissolving the 
crystalline bovine PNMT [Sigma Chemical Co., U.K.] in tris buffer 
(PH = 8.8) was made. These two standards, low and high [four per set] 
were of the same range as the unknown samples. The consistency of 
these standards from assay to assay gave a reliable indication that 
the assay was working satisfactorily.
On the day of assay:
(a) lOjul of BHPEA (0.2pmol) was added to unknowns and external 
standard samples and IOjjI double distilled water to the £issue blanks 
in place of BHPEA.
(b) An aliquot of the reaction mixture containing 20jj1 of 0.2M 
tris buffer (pH = 8.8), 4pl BSA (2%, w/v), 4jj1 DTT (0.3% w/v), 0.42jj1 
(185pmol) of cold SAM [Sigma Chemical Co., U.K.], 2.92jj1 (193pmoles) 
of hot SAM (specific activity, 15Ci/mmol, Amersham International) was 
added to ’tissue blanks’, ’unknowns’ and to external standards in a 
final volume of 125pl. All the three sets of tubes were incubated 
for Ih at 37°C.
(c) The reaction was stopped after Ih by placing the.tubes in 
ice bath and adding 500pl borate buffer (pH = 10) and vortex-mixed 
briefly. Then 2ml toluene/isoamyl alcohol was added and vortex-mixed 
for 30s.
(d) These were centrifuged at 15,00g at 10°C for lOmin.
(e) 1.6ml of the organic phase was transferred to 3" x h" silanized 
glass tubes containing 1ml of O.IM HCl containing Na2S20^ (0.1% w/v) and 
vortex-mixed for 30s.
(f) These wre again centrifuged at 15,00g for lOmin and the organic 
phase aspirated. From the aqueous phase 0.8ml was transferred to 
scintillation glass vials containing 1ml 0..1M HCl/Na2S20^(o.1% w/v).
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(g) The vials were placed in a chromatographic oven overnight 
for drying at 75°C. Next day, 5ml ACS II was added to the vials, mixed 
for 30s and counted on a jB> -counter after leaving them at room temperature 
for >lhr.
3.5 Calculations r
The recommended unit of an enzyme activity is the ’Ratal* which is 
defined as the amount of enzyme that converts one mole of substrate 
per second and specific activity as ’Ratal’ per killogram, but it has 
commonly been used as pmole per hour and specific activity pmole per 
hour per milligram by other workers (Saavedra et al.,1974b; Pendleton 
et al., 1977; Luine and McEwen, 1983). This commonly used unit had 
been used throughout in this report.
3
Activity was expressed as pmol of phenylethanolamine-N-[methyl- H] 
formed per hour (pmol/h) and Specific Activity as pmole per hour per 
milligram (pmol/h/mg). This was evaluated by using a pre-programmed 
computer [Apple II]. Since the counting efficiency was constant in 
the present assay, the requirement for the determination of absolute 
radioactivity (DPM) was unnecessary, however, two measurements were 
required in order to evaluate the activity;
(a) the total radioactivity (CPM) corresponding to the added hot 
SAM per tube. Since 2.92 /jCi was added to the assay tubes, this amount 
of hot SAM was added to scinillation vials containing 5ml ACS II and 
counted on a Packard p-counter. This gave 2051911 CPM (total radio­
activity) .
(b) the total amount of SAM. Since both cold and hot SAMS were 
added to each tube, the total amount of SAM = cold + hot; 185pmol +
193 pmol = 378 pmoles [total amount of SAM]. From these two measure­
ments specific activity of PNMT for pheylethanolamine can be calculated
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provided always that the fraction of the radioactivity (corrected CPM)
3
appearing with the product, pheylethanolamine-N-methyl-^H]and protein 
content of the sample are known.
The procedure for calculating specific activity is outline below:
(a) subtract the ’tissue blank’ values (background CPM) from the 
fraction of the radioacdtivity appearing with product (unknown samples 
CPM) [unknown samples CPM-background CPM = corrected CPM] ;
(b) multiply the corrected CPM with total amount of SAM [corrected
CPM X 378 pmoles] and then divide it by the total radioactivity [2051911];
ited CPM 
2051911PNMT activity - ôTTrTqT ï---- "  pmol/hr since the tissue was incubated
per hour at 37°C;
(c) finally the results can easily be converted to specific activity 
by dividing it with protein content (mg) of the sample.
Therefore,
specific activity = P-l/hr/»g
3.6 Precision, Sensitivity and Specificity
Precision was determined by the inter and intra-assay coefficients 
of variation and these were 13% and 7.8% respectively. The sensitivity 
(2 X S.D.of ’tissue blank’ value) of this assay was Ipmol/hr/mg protein.
3
Since in the assay described in this section only negligible [Hlcounts 
per minute were obtained when using tryptamine or pheylethylamine as 
substrate, in contrast to j3-hydorxypheylethylamine, the assay is highly 
specific for PNMT. Furthermore, it mimics the in vivo situation in 
which noradrenaline containing a hydroxyl group at ^  -position is N- 
methylated to adrenaline by the brain PNMT.
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Chapter Three
ELICITATION OF THE LH SURGE IN IMMATURE RATS IN RESPONSE TO OESTROGEN 
Introduction :
It is generally accepted that hypothalamo-hypophysial-gonadal negative 
feedback mechanisms in both male and female rats are functional during 
the neonatal stage of development (Goldman et al., 1971; Eldridge .et al., 
1974). However, mechanisms responsible for a gondatrophin positive 
feedback response to an oestrogen stimulus are synchronized on the 
day preceding the first natural onset of ovulation in young females 
(Meijs-Roelofs et al., 1975), whereas male rats are incapable of such 
a response at any age (Dohler & Wuttke, 1974).
In short-term (acutely ovariectomized rat model) ovariectomized adult 
rats (Mackinnon et al., 1985) and long standing ovariectomized adult 
rats (Calgaris et al., 1971; Burnet & Mackinnon, 1975), a massive out­
put of gonadotrophin (IH)similar to that seen in intact cyclic proestrous 
rats can be elicited by treatment with 1 7 JB -oestradiol-3-benzoate (OE2, 
Sigma Chemicals Co. Ltd., U.K.). Furthermore, immature rats of 27— 
days of age and under 60g body weight when treated with pregnant mare 
serum gondatrophins (PMSG) showed an LH surge 52-54h after an initial 
injection (s.c) of PMSG, but they do not ovulate (ter Haar & Wilson,
1978). Similarly, in a previous ontological study of the 0E2-stimulated 
gonadtrophin surge, it was found that the occurance of this neuro- 
humoral event was critically related to the age and sex of the animal.
It could be elicited in 21-day-old females, but not in lé-day-old females 
or in males of any age (Puig-Duran & Mackinnon, 1978b); these 21-day- 
old animals, however, do not ovulate. The preliminary experiments presented 
in this chapter were undertaken to confirm earlier findings in our 
present colony of rats since this was a model that I wished to use 
for further studies (see Chapters 4 and 5).
 ^ ■
Materials and Methods
Animals :
Wistar rats of both sexes aged 16, 18, 20, 21 and 22 daySwere 
used in this study. They were taken from litters which had been culled, 
within 24h of birth, to a total of 8 (male and female) pups. Each 
litter was kept with their mother in a single cage until they were 
weaned at 21-day5 of age. Lighting and temperature in the animal house 
were automatically regulated (lights on 0600h: lights off 2000h; 
temperature 22±2°C), and food (Diet FFG; Dixon & Sons, Ware) and water 
were freely accessible to the animals.
Experimental procedures;
1. Groups of 16, 20, 21 and 22—day-old male and female rats were 
injected (s.c) through the scruff of the neck with 1/jg OEg in 0.1ml 
arachis oil:ethyl oleate (4:1, v/v) at noon on experimental day 1 (as 
described by Puig-Duran & Mackinnon, 1978a) and decapitated at either 
lOOOhor 1800h on day 3. Previous studies have shown that these are 
the times when minimum (lOOOh) and maximum (1800h) concentrations of 
serum LH are found (Puig-Duran & Mackinnon, 1978a,b).
2. 22-day-old male and female rats were injected (s.c.) with oil or OE2 at 
noon on experimental day 1 and decapitated at either 1500h, 1600h/ 1700h, 
1800h or 1900h on day 3.
Collection of blood samples:
Blood samples were taken by draining the trunk after rapid decapitation.
The blood was allowed to clot in a PTF 1289plastic tube for 4-5hr in 
the cold (4°C) and then centrifuged at 4®C for 15min. The serum was 
then collected into LP2 tubes, frozen, and stored at -20°C until the 
time of assay.
Measurements of concentrations of LH in serum samples:
Serum LH concentrations were measured by an ovine—ovine radioimmuno assay
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(RIA) as described in Section 'A’ of Chapter 2.
Results t
Serum LH concentrations (NIH-LH-S13, jjg/1 in OEg-treated 16, 18, 20, 21 
and 22-day-old male and female rats;
Immunoreactive serum LH concentrations in infant male rats (16-22
days of age) injected (s.c.) with OEg on experimental day 1 and decapitated
on day 3 at either lOOOh or 1800h were baseline (Table II). Similarly,
16, 18-day-old OE^-treated (day 1) female rats showed basal levels at 
either lOOOh or 1800h on day 3, with the exception of two 18-day-old 
animals which showed considerably higher concentrations of LH at 1800h 
(Table III). With respect to the groups of 20, 21 and 22-day-old female 
rats, LH concentrations were at basal level at lOOOh, while all the 
animals showed much higher LH levels at 1800h; with the exception 
of two 20-day-old rats which showed baseline values (Table III). The 
concentrations of immunoreactive LH in the serum of 22-day-old female 
rats injected with OEg on day 1 were much higher at 1800h than at 1700h 
or 1900h (Table .V ). There were no differences in serum LH concentrations 
at either 1700h, 1800h or 1900h in similarly treated 22-day-old male 
rats 5 (Table .V) and loll injected (s.c.) 22-day-old female rats/Table IV). 
Discussion:
It could be argued that jugular venepuncture under ether anaesthesia 
is preferable to collection of trunk blood at decapitation, since it 
would have enabled both blood samples (lOOOh and 1800h) to be taken 
from the same animal. However, previous studies have shown that jugular 
venepuncture which involves both handling and anesthesia prior to bleeding 
causes a complete disappearance of episodic bursts of high LH levels 
observed in immature rats of both sexes (between 4 days and the onset 
of puberty) (Mackinnon et al., 1976). Furthermore, it is generally 
accepted that rapid decapitation minimises the effects of stress (e.g.
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Profiles of the concentration of immunoreactive LH (;jg/l) in the serum of 
immature rats injected (s.c.) with oestradiol benzoate (OE^) at I200h on 
day 1 and decapitated at either 1700, 1800 or 1900hon day 3
22-day-old female (Ç) rats
1700 h 1800 h 19001 h
No. LH No. LH No. LH
1 0.A5 1 >32.00 1 2.AA
2 1.99 2 >32.00 2 10.96
3 0.25 3 >32.00 3 >32.00
A 1.29 A >32.00 A 22.30
5 0.99 5 >32.00 5 10.58
6 1.12 6 >32.00
7 0.63 7 6. AO
8 12.55 8 >32.00
9 1.10 9 >32.00
10 >32.00
22-day-old male ((?) rats
1700 h 1800 h 1900 h
No. LH No. LH No. LH
1 1.A3 1 0.80 1 0.37
2 0.A6 2 0.36 2 0.60
3 1.91 3 N O 3 N O
A 0.28 A 1.57 A 1.01
3 0.33 5 0.68 5 0.27
6 N O 6 0.35
7 0.32 7 3.90
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Dohler et al., 1976).
Measurements of LH concentrations in oil- treated female 
rats (see Table IV) did not show an increased LH surge and thus served 
as a ’control group’. Serum LH concentrations in 2 out of 6 of the 
OEg-stimulated 18-day-old female rats at 1800h on day 3 were considerably 
higher than basal levels (see Table III). However, these LH levels cannot 
be considered as an LH surge since they were much lower than that of 
endogenous oestrogen-stimulated proestrous rats (Mackinnon et al.,1983). 
Of the experimental OEg-treated 20-day-old female rats, 3 out of 5 showed 
a surge output of LH at 1800h on day 3, while 2 showed only basal levels 
(see Table III). A clue to the possible explanation for this observation 
that a proportion of 18—day, and 20—day-old experimental animals respect­
ively showed a considerable increase in the concentrations of LH as 
compared to their litter mates, comes from a previous study (ter Haar 
& Wilson, 1978). In that study both lighter (<60g) and heavier (>60g) 
weight 27-day-old animals when treated with PMSG on experimental day 1 
showed a surge of LH with a peak at 1800h on day 3, as measured by the 
heterogenous radioimmuno assay (ovine-ovine RIA, described in materials 
and methods). However, similarly treated, heavy weight animals showed
of LH on day 3, as^^m the homologous RIA (rat_anti-_______
serum, purified rat LH for iodination and rat LH standards-system) 
and furthermore, these animals ovulated on experimental day 4 (Wilson 
et al., 1985). It has been suggested that a surge of LH which was 
shown by lighter animals might be a pleiomorphic form which is inactive 
and, consequently did not cause ovulation. Whereas a change in the 
structure of LH, (active form), in association with the weight (>60g) 
of animals might be responsible for causing the ovulation. Furthermore, 
using this PMSG-treated prepubertal rat model it was suggested that
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the influence of body weight might play a critical role in the onset 
of puberty (Wilson et al., 1983). If this were the case then it is 
likely that a proportion of both 18, and 20-day-old females which showed 
a considerably high level of LH might also have had higher body weight 
as compared to their litter mates.
Possibly, it can be said that body weight of these animals might be 
worth taking into consideration during the course of such studies and 
this was followed in the remaining studies presented in this thesis.
With respect to 16-day-old female rats (Table III) the failure of 
a gonadotrophin response to an oestrogen stimulus as compared to 22-day- 
old females could have been due to the presence of much higher levels 
of X-foeto-protein which has a high affinity for oestrogen (Raynaud 
et al., 1971). This protein, which is produced in foetal liver, declines 
steadily from birth to 21-days of age .(Nunez et al., 197^). However, 
in rats treated with diethylstilboestrol, a synthetic oestrogen which 
does not bind avidly to c<-foeto-protein, the gonadotrophin positive 
feedback response was also prevented (Puig-Duran & Mackinnon, 1978b).
An explanation as to why these animals did not show a gonadotrophin 
positive feedback response still remains to be ascertained.'
The profiles of the concentrations of LH in the 22-day-old males and 
females showed that peak values occurred at 1800h on day 3, while none 
of the similarly treated male rats showed a gonadotrophin response to 
an oestrogen stimulus ( Table V). Furthermore, in the present study, 
none of the experimental male rats (16-22 days of age) responded to 
oestrogen with a release of LH at 1800h on day 3 (Table II). This 
is in agreement with previous studies in which the presence of oestrogen 
or testosterone during a developmental critical period (i.e. within 
5 days post-partum) was shown to masculinize the brain and therefore
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prevent the IH surge response to an oestrogen stimulus at any age 
(Barraclough, 1961; Gorski, 1963).
In conclusion, serum LH levels of OE^-treated 16 and 21 or 22-day-old 
females and males of 16-22 day of age measured at both lOOOh and 1800h 
on day 3 are compatible with those shown in a previous study (Puig- 
Duran and Mackinnon, 1978a, b).
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Chapter Four
CHANGES IN ADRENALINE CONCENTRATIONS IN THE MEDIOBASAL HYPOTHALAMUS OF 
IMMATURE RATS INDUCED WITH OESTROGEN.
Introduction;
Recently, a series of studies using an inhibitor, (SKF64139) of the 
centrally active adrenaline synthesizing enzyme (PNMT) has indicated 
that adrenaline might play a critical role in the output of the pre­
ovulatory surge of LH (Crowley & Cass-Terry, 1981; Crowley et al., 1982; 
Coen et al., 1983). Investigations of adrenergic activity in the MPOA 
and MBH of regularly cyclic proestrous rats have shown that activity 
increases during the neural 'critical period'. Moreover, it is oestrogen- 
dependent and can be blocked by pentobarbital (Mackinnon et al., 1983; 
1985). These investigations supported the suggestion that steroid- 
stimulated adrenergic activity in the MBH may be concerned with the 
preovulatory release of gonadotrophins.
It has been previously observed, and also confirmed by the present studies 
(see Chapter 3), that 21-,or 22-day-old female rats if injected (s.c.) 
with oestradiol benzoate (OEg) at noon on experimental day (day 1) show 
an LH surge 54h later, at 1800h on day 3. Moreover, this surge in output 
of LH is similar in timing and magnitude to that of the cyclic proestrous 
and chronically ovariectomized oestrogen-stimulated adult rats. Similar 
treatment of either 16-,18-;20— ,21-,and 22—day—old males or 16—day—old 
females has not shown such a response. The experiments presented in this 
chapter were undertaken to ascertain whether central adrenaline is 
indispensible for the production of LH surge on OE2—treated immature rats. 
Adrenaline concentrations were measured in the MPOA and MBH of infant rats 
at pertinent times after an initial injection of OE2.
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Materials and Methods 
Animals :
Wistar rats of both sexes aged 22 day: (mean body weight (b.w.) 46 ± 2 
(S.E.M.) g) and 16-day-old females (25 ± Ig (b.w.)) were used in this 
study. Care and handling of the animals have been described in Chapter 3. 
Experimental procedures;
1. 22-day-old males and females were injected (s.c.) with Ipg OE2 in 
0.1ml arachis oil;ethyl eoleate (4;1, v/v) at noon on experimental day 
(day 1) (as described by Puig-Duran & Mackinnon, 1978a) and decapitated 
at hourly intervals between 1200h and 1800h of day 3.
2. 22^.and 16-day-old female rats were injected with Ipg OE2
on experimental day 1 and decapitated at either 1500, 1600 or 1700h of 
day 2 and day 3 respectively.
The MPOA and MBH samples were removed as described previously (see 
Section B of General Materials & Methods) and homogenized either in 25j j 1 
O.IM HCl solution containing ImM diethylenetriaminepenta acetic acid and
0.1% sodium metabisulphite (see Section ’C  of General Materials & Methods) 
for subsequent measurements of adrenaline.
Catecholamine concentrations in the MPOA and MBH
A radioenzymatic assay was used for measurements of DA, NA and A in the 
MPOA and MBH. This assay with small modifications, was that described 
by Sailer & Zigmdnd (1978) (see Section ' C  of General Materials & Methods 
for details).
Glassware;
Glass tubes were used for the radioenzymatic assay of catecholamines.
These tubes were silanized by exposing them to the fumes of dimethyldichloro-
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silane in a fume-tight vessel for a period of at least 24hrs. Before use 
they were rinsed with distilled water and dried in an oven.
Expression and statistical analysis of results:
The results mentioned in this chapter are expressed in terms of total 
tissue protein, the form which is most commonly encountered in the 
literature. However, some authors have expressed their results in terms 
of wet weight (Glowinski & Iversen, 1966 ). It was not feasible to exploit 
this technique since the frozen samples of MPOA and MBH were too small to 
handle accurately without loss of weight. The protein in tissue samples 
was measured by the method of Lowry et al., (1951) (see Appendix • for 
details).
Statistical significance of differences between group means was assessed 
with a Newman-Keuls test, if warranted following analysis of variance 
(Winer, 1971). A value for P^O.05 was regarded as significant.
Results :
Concentrations of catecholamines (ng/mg Protein in the MBH and MPOA of 
oestrogen-treated infant rats:
Mean concentrations (IS.E.M.) of adrenaline (ng/mg Protein) in the MBH 
of both 22-day-old male and female rats treated with OEg on experiemntal 
day 1 were at baseline levels between 1200h - 1800h on day 3 (Fig.15).
The exception, however, was that of adrenaline concentrations in the MBH 
of females at 1600h which were significantly higher at 1600h than at 
either 1500h (P<0.01) or 1700h (P<0.01) both on days 2 and 3 (Fig.17).
The concentrations of adrenaline in the MPOA of these rats of either sex 
also showed basal levels at 1500h, 1600h and 1700h on day 3 (Fig.16). 
Likewise, similarly treated 16-day-old female rats showed basal levels 
of adrenaline in the MBH at 1500h, 1600h and 1700h on day 3 (Fig.17).
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Fig.15. Mean adrenaline (A) concentration (IS.E.M.) in the mediobasal
hypothalamus of 22-day-old male ( ) or female ( )
rats injected (s.c.) with Ijjg oestradiol benzoate (OE2) at 1200h on 
experimental day 1. Groups of animals were decapitated at one-hourly 
intervals between 1200h and 1800h on day 3. The number of animals used 
is shown in brackets. ■
** 1600h : 1500h (P<0.01)
1600h : IVOOh (P<0.01)
(12) (5)
1200 1300 1400 1500 1600 1700 1800 1900
Time (h)
TABLE VI
Kean adrenaline concentrations ng/mg (+ S.E.M.) in the mediobasal hypothalamus 
of 22-day-olc female rats injected with oil [arachis oil: ethyl oleate, 6:1
(v/v)] at 1200 h^on experimental day 1. Groups of animals were decapitated at 
15G0h, 16000 or i700n on day 3. The number of animals used is shown in 
brackets
1300 h 1500 h 1700
95A
66+0.21 3.00+0.39 1.91+0.26
(3) (4) (4)
Fig.16. Mean adrenaline (A) concentrations (tS.E.M.) in the medial 
preoptic area of 22-day-old male ( ) or female ( )
rats injected (s.c.) with Ijjg oestradiol benzoate (OE2) at 1200h on 
experimental day 1. Groups of animals were decapitated by 1500h,
1600h or 1700h on day 3. The number of animals used is shown in 
brackets.
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Fig.17. Mean dopamine (DA), noradrenaline (NA) and adrenaline (A) 
concentration (IS.E.M.) in the mediobasal hypothalamus of 16-day-old
2 ) female rats injected (s.c.) 
with Ijjg oestradiol benzoate (OE2) at 1200h on day 1. Groups of 
animals were decapitated at 1500h, 1600h or 1700h on either day 2 
or day 3. The number of animals used is shown in brackets.
* 1700h
1700h 
** 1600h 
1600h
1500h (P<0.05)
1600h (P<0.05)
1500h (P<0.01)
1700h (P<0.01)
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There were no significant differences in the concentrations of either
DA or NA in the MBH of OE^-treated 16, and 22-day-old female rats
decapitated at 1500h, 1600h or 1700h on either day 2 or day 3; with the
exception of NA concentrations in the MBH of 22-day-old rats at 1700h
on day 3 which were significantly higher than at 1500h (P<0.05) or
1600h (P<0.05) (Fig.17). There were no significant differences in the
concentrations of A in the MBH of oil-treated 22-day-old female rats
decapitated at 1500h, 1600h or 1700h on day 3 (Table VI).
Discussion;
The turnover of a metabolite in a cell refers to that amount which is 
transported or metabolized. It is generally accepted that measurements 
of turnover rate of a neurotransmitter is a sensitive index of its 
functional activity (Pycock & Tabener, 1981). In order to measure 
the turnover of catecholamines, two main types of method have previously 
been used, namely, Radioisotopic labelling and Enzyme inhibition. In 
the radioisotopic method a suitable labelled precursor is introduced 
into the brain either by infusing into the ventricle or through the 
bloodstream. The rate of change of the amount of this isotopically
labelled substance present in the brain is subsequently measured. The
use of this method came from a study in which labelled noradrenaline
3
(0.22jjg, [ H]-noradrenaline, Sp.activity 5 Ci/mmol) or dopamine (l.Sjjg
3
[ H]«dopamine, Sp.activity 1.5 Ci/mmol) were injected in a volume of
20 - 30jjl into the lateral ventricle of the rat brain by stereotaxis
to avoid the blood-brain barrier, (Iversen & Glowinski, 1966). These 
research workers determined the half life values [t^ = (^°®10)/slope] 
from the initial rate of decline of labelled noradrenaline, or 
noradrenaline synthesized from labelled dopamine in different parts 
of the brain. The turnover noradrenaline which is the product of the 
half life and the initial concentration of labelled noradrenaline in 
the tissue was then calculated. However, radioisotopic labelling is
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open to criticism. The criticism is that not all of the catecholamine 
injected into the lateral ventricles is taken up by the appropriate 
nerve terminals. Such non-specific radioisotopic labelling might 
induce artifacts. Furthermore , the intraventricular addition of 
labelled catecholamine might saturate the endogenous amine pools; and 
in turn this might consequently alter the kinetics of the enzymes 
responsible for synthesizing or metabolizing these amines.
In the second method which pertains to enzyme inhibition, either the 
activity of a neurotransmitter metabolizing enzyme or that of its 
synthesizing enzyme is blocked; thereafter, the accumulation of 
neurotransmitter or the decline in its concentration are measured 
respectively. However, the measurements of adrenaline or its metabolite, 
metanephrine as an index of adrenergic activity after monoamine oxidase 
inhibition has not been feasible due to a feedback effect on the 
synthesizing enzyme (PNMT) (Fuller & Hunt, 1967). The turnover rate of 
adrenaline in discrete regions of the rat brain, as measured by the 
decline in concentration of adrenaline following inhibition of PNMT 
has been reported (Sauter et al., 1978; Fuxe et al., 1979). However, 
turnover measurements of adrenaline have not been made in the present 
studies since pharmacological suppression of catecholamine transmission 
is also open to criticism. One piece orf evidence indicated^ that inhibitors 
of PNMT possess oC-adrenergic receptor antagonist activity (Toomey et al., 
1981) and in addition, inhibit monamine oxidase activity (an enzyme 
responsible for metabolising catecholamines) (Fuller et al., 1983).
It is possible therefore that increased turnover of catecholamines 
shown by previous studies might be due to receptor antagonism and/or 
monoamine oxidase inhibitory activity of the pharmacological agents 
used. Furthermore , an increased turnover of NA, as measured by its
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rate of decline following the adminstration (i.p.) of a drug { CK - 
Methyl-p-tyrosine, -MPT) which inhibits tyrosine hydroxylase, was 
consistently accompanied by an increase in baseline levels of NA 
(Ranee et al., 1981; Hiemke et al., 1985). Similarly in the MBH 
of adult rats, an increased turnover of adrenaline (as measured by 
its rate of decline, 2h after following a drug, SKF64139 induced 
inhibition of PNMT) was invariably seen to accompany an increase in 
baseline concentrations (Sheaves et al., 1985a). This suggests that 
an increased turnover of a catecholamine found in previous studies 
was merely due to enhanced baseline values.
Using 30-day-old female rats injected (s.c.) with pregnant mare serum 
(RMS) on experiment day 1, it has been shown that ovulation can be 
elicited about 64h later, on day 4 (Strauss & Meyer, 1962). Further­
more, the animals were injected (i.p.) with barbiturate at different 
times during day 3, in order to determine a neural 'critical period'.
It was found that the time of a neural 'critical period' in this PMS 
treated prepubertal rat model was similar to that of adult rats (Everett 
& Sawyer, 1950). Therefore, it is likely that a neural 'critical period' 
in 22-day-old female rats treated with OE2 on day 1, occurs at the same 
time on day 3 as in adult proestrous rats of our colony ('critical 
period', 1430-1700h.
An increased adrenaline concentration during the 'critical period' in 
the MBH of OE^-treated (day 1) 22-day-old female rats (decapitated at 
1600h on day 3 which precedes the LH surge), was absent in the MPOA of 
these animals (Fig.16). These findings are in agreement with a 
previously reported study in which it has been shown that an OE^-stim- 
ulated increase in adrenaline concentrations in the MBH of acutely 
ovariectomized adult rats, occurred during the 'critical period'.
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followed about 2h later by an LH surge. Infant male rats under similar 
treatment did not respond to an 0E2-stimulus in releasing the output of 
LH and furthermore, did not show an increase in the concentration of 
adrenaline in the MBH at 1500h, 1600h or 1700h on day 3 (Fig. 15). On the basis 
of these observations, it is tempting to suggest that an increased 
adrenaline concentration in the. MBH of 0E2-treated 22-day-old females 
on day 3 might be involved in the mechanism underlying the critical 
period which is presumably associated with the output of GnRH and hence 
the LH surge. Whether the increase of adrenaline concentration in the 
MBH represents an increased synthesis of the neurotransmitter or an 
accumulation of its concentration, due perhaps to a decrease in its 
release or decreased monoamine oxidase/COMT activity is not known.
Moreoever, the precise location of the increased concentrations of A 
in the MBH of infant rats is not known, although measurements of A in 
the arcuate nucleus and in the medial and lateral aspects of the median 
eminence of cyclic proestrous rats have shown that at least 80% is 
concentrated in the ME, mainly in its lateral aspects (Sheaves et al.,
1984). According to Ranee et al., (1981), increased noradrenergic 
activity in the MPOA might represent the neural mechanism underlying the 
neural 'critical period'. A further study by Ranee & Barraclough (1981) 
concerned with the measurement of noradrenergic activity in the MPOA of 
pentobarbital blocked adult rats did not support this suggestion, since 
it was observed that the noradrenergic activity was not significantly 
affected by pentobarbital blockade. The present study of 22-day-old 
female rats 0E2~treated on experiment day 1 and decapitated at either 
1500h and 1600h or 1700h on day 3 did not show an increase in either A 
and NA or DA concentration in the MPOA. Furthermore, an increased 
noradrenergic activity in the MBH at proestrous (1200-1500h) concomitant 
with a fall in the hypothalamic content of GnRH and an increase in
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plasma LH levels, have also been reported and interpreted as representing
processes involved with the initiation of the LH surge (Ranee et al.,
1981). However, barbiturate injected in an ovulatory-blocking dose at
the start of this period (1200h) failed to effect this noradrenergic
activity (Ranee & Barraclough, 1981). On the other hand, adrenaline
turnover in the MBH has been shown to be diminished significantly between
14.30 and 16.30h (during the critical period) in proestrous rats which
had been injected with pentobarbital (Sagatal; i.p., 36mg/kg) in an
ovulatory-blocking dose at the start of the critical period (Mackinnon 
et al., 1983).
To ascertain whether increased adrenaline concentrations in the MBH are 
specifically associated with the output of LH surge on day 3, catechola­
mine concentrations were measured in the MBH of 22-day-old female rats 
injected with OE2 on experimental day 1 and decapitated at either 1500h 
and 1600h or 1700h on day 2, which does not seem to be associated with the 
output of LH. It was found that mean concentrations of adrenaline were 
significantly higher at 1600h than at either 1500h (P<0.01) or 1700h 
(P<0.01) similar to day 3, while DA and NA concentrations were at baseline 
level (Fig.17). These observations might indicate that an increased adrenaline 
concentration in the MBH preceding the LH surge on day 3 might not be 
specifically associated with its output. In the previous measurements 
of serum prolactin concentrations in 21-day-old female rats using the 
same experimental regime, it has been shown that prolactin concentrations 
were significantly higher at 1800h than at 0900h both on days 2 and 3 
(Puig-Duran & Mackinnon, 1978a). It is generally accepted that tubero- 
infundibular dopamine is one of the factors which inhibits the output of 
prolactin at the anterior pituitory level (reviewed by Leong et al., 1983).
An important piece of evidence came from a study in which the concentra­
tions of dopamine in the hypothalamo-hypophysial portal blood were 
measured during the oestrous cycle (Ben-Jonathan et al., 1977). It has
102
been found from this study that the pro-oesetrous surge of prolactin is 
accompanied by a fall in dopamine level in the portal blood. A fall in 
dopamine in the portal blood probably reflects its release having been 
inhibited into the portal vessels. If this were the case then it 
should be possible to measure an accumulation of dopamine in the MBH. 
However, in the present study variations in the concentrations of dopamine 
in the MBH of 22-day-old female rats OEg-treated on day 1 were not found 
either on experimental day 2 or 3 (Fig.17). It is possible that the 
accumulation in the concentration of dopamine is not sufficient to be 
detectable.
There is growing evidence to suggest that thyrotrophic-releasing hormone 
(TRH) might be one of the factors responsible for the stimulation of the 
proestrous output of prolactin (reviewed by Leong et al., 1983). In 
support of this hypothesis an increase in the number of TRH receptors 
on the lactotrophs has been found on proestrus (Delean et al., 1977). 
Furthermore, measurements of TRH concentrations in the hypothalamo- 
hypophysial portal vessels during the oestrous cycle showed that TRH 
increased on the afternoon of proestrus (Franks et al., 1984). Based 
on these findings, it has been proposed that oestrogen influences the 
outut of TRH into pituitary portal blood which intereacts with lactotrophs 
in releasing prolactin (Frank et al., 1984). It is possible that the 
increased concentrations of adrenaline both on days 2 and 3 in the MBH of 
the 0E2“treated infant model, may be temporally related with the output 
of prolactin, possibly by mediating the oestrogen response to TRH and 
thereby regulating its output into the portal vessels. However, it could 
be argued that adrenaline is a general modulator involved with the output 
of pituitary hormones and operating either at the level of the anterior 
pituitary or at the MBH. This suggestion is supported by two pieces of 
evidence:
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(s) 22 day old male rats injected with OEg at noon on experimental day 1 
did not show an increased output of serum prolactin 30h later (i.e. 1800h 
on day 2) or both prolactin and LH 54h later at 1800h on day 3 (Puig-Duran 
& Mackinnon, 1978a), a finding that was confirmed with respect to the output 
of LH in the present study. Failure to respond to an OEg-stimulus in 
releasing the prolactin on day 2 or prolactin accompanied by LH surge on day 
3 was associated with an absence of an increased adrenaline concentration 
in the MBH (Fig.15).
(b) With respect to the 16-day-old female rats, failure to respond to an 
oestrogen stimulus was again associated with an absence of an increased 
concentration of adrenaline in the MBH at 1500h, 1600h or 1700h on day 3 
(Fig.17). However, the same argument pertaining to the presence of (K - 
foeto-protein can be implied as described previously (see Chapter 3).
Since there is considerable current interest in the possible roles of DA 
and NA in the control of hormonal output from the anterior pituitary 
(Weiner & Ganong, 1978; Barraclough et al., 1984) it was notable that 
concentrations of DA and NA in the MBH remained at baseline levels during 
the time of sampling (1500 — 1700h on days 2 and 3), with the exception 
of NA concentrations at 1700h which were significantly greater than those 
at 1500h or 1600h (P<0.05, Fig.17). This finding may relate to the increase 
in NA turnover which Ranee et al., (1981) consider it to be related to the 
proestrous surge.
In conclusion, an oestrogen—stimulated increase in adrenaline concentration 
in the MBH occurs not only in the proestrous adult and 0E2-treated ovar­
iectomized rat, but also in the OE2—treated immature female rat. This event at 
least in the proestrous adult and the OE2—treated ovariectomized rat is 
associated with a higher turnover of adrenaline and presumably increased 
adrenergic activity. It is also worth noting that in the proestrous rat
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the timing of the short-lived adrenergic activity occurs during the 
neural critical period. This increase in adrenaline concentration 
which can be elicited at 21-days of age but not before, is also sexually 
differentiated. Since adrenaline activity in the MBH increases 
consistently 2h before an outpouring of anterior pituitary hormones, 
there would seem to be a strong temporal relationship between the two 
events. Whether or not there is a direct relationship remains to be 
investigated.
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Chapter Five
INVOLVEMENT OF OESTROGEN AND CORTICOSTEROID IN INDUCING CHANGES IN 
PHENYLETHANOLAMINE-N-METHYL TRANSFERASE ACTIVITY IN THE MEDIOBASAL 
HYPOTHALAMUS OF IMMATURE RATS.
Introduction:
Using the oestrogen-stimulated infant rat model, it was found that a 
marked but short-lived increase in adrenaline concentration occurred 
in the MBH of 22-day-old female rat both on days 2 and 3, whereas 16- 
day-old females or 22-day-old males did not show such a response (see 
Chapter 4). This increase in adrenaline concentration is temporally 
related to an output of pituitary hormones 2h later. But whether this 
increase is due to an increase in its synthesis, a decrease in its 
release, or a decrease in monoamine oxidase and/or catechol-o-methyl 
transferase, is not known. However, the regional distribution of 
phenylethanolamine-N-methyl transferase (PNMT) in the rat brain as 
measured by immunohistofluorescence (Hokfelt et al., 1974, Lew et al., 
1977) or PNMT activity Saavedra et al., 1974b) is consistent with a 
parallel distribution of adrenaline concentrations (Koslow & Schlumpf 
1974). Furthermore, the interpretation of turnover of adrenaline is open 
to criticism as described in Chapter 4. One way to alleviate this problem 
of interpretation is to measure PNMT activity.
In the light of the above observations the ontological and sexually- 
related changes in activity of PNMT were measured. Data from several 
reports have indicated that the activity of choline acetylase (the 
enzyme which synthesizes acetylcholine) in the rat brain can be affected 
by changing plasma concentrations of gonadal hormones (Luine et al., 1975; 
Muth et al., 1980; Luine & McEwen, 1983. It is possible that adrenergic 
mechanisms may participate in the mediation of oestrogen-dependant
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gonadotrophin output by affecting PNMT activity.
It is well documented that adrenocorticotrophin (ACTH) interacts with 
specific receptors in the adrenal cortex to stimulate an output of 
glucocorticoids. Glucocorticoids diffuse through the adrenal medulla 
before entering the blood stream and thereby modulate medullary PNMT 
activity (Ciaranello et al., 1978; reviewed by Ungar & Phillips, 1983; 
and Carmichael & Winkler, 1985). It is possible therefore that 
glucocorticoids may play some role in changing the actvity of central 
PNMT in the oestrogen-treated infant rat.
The experiments described in this chapter were also undertaken to explore 
these two possibilities that oestrogen and corticosteroid might influence 
the PNMT activity. PNMT activity was measured in the MBH of intact or 
adrenalectomized infant rats after treating them with oil, oestrogen 
or dexamethasone.
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Materials and Methods
Animals
22-day-old Wistar rats of both sexes with a mean body weight (b.w) of 
46±2 (S.E.M.)g and 16-day-old females (25±lg, b.w.) were used in this 
study. The care and handling of the animals have been described in 
Chapter 3.
Experimental Procedures:
1. 16-day-old females and 22-day-old males and females were injected 
(s.c.) with Ijjg OE2 in 0.1ml oil [arachis oil: ethyl oleate, 4:1 (v/v)] 
or oil vehicle only on experimental day 1, and decapitated between
1400 - 1800h on day 3.
2. Groups of 22-day-old females were treated with oestrogen as described 
above and decapitated at 4-hourly intervals starting at 1200h on day 2 
and ending at 2000h on day 3.
3. Further groups of 22-day-old female rats were adrenalectomized
[using a dorso-lateral abdominal approach under ether anaesthesia] on 
day 1 and thereafter allowed free access to either drinking water con­
taining 1% glucose, 0.9% ethanol and 0.40mM dexamethasone or drinking 
water containing 0.9% ethanol and 1% glucose. This drinking fluid was 
made up of 16ml of dexamethasone to 0.9ml of absolute alcohol. This was 
then gradually added to 99.1ml of drinking water containing Ig of glucose, 
while being stirred continuously (personal communication. Dr. Julia 
Buckingham). These animals were injected (s.c) with Ipg OE2 on day 2
and decapitated at either 1500h, 1600h or 1700h on day 4.
Brains were removed and prepared for PNMT measurements as described
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previously (Section 'D’ of General Materials and Methods).
All glassware in this assay was silanized (see Chapter 4).
Statistical analyses;
Statistical treatment of the data was by analysis of variance for unequal 
groups followed by the Newman-Keuls procedure. P^0.05 was considered 
to be significant (Winer, 1971).
Results :
Mean specific activities of PNMT (Pmol/h/mg) in the MBH and MPOA of the 
oestrogen-treated infant raf;
Mean specific activity of PNMT (Pmol/h/mg Protein) in the MBH of oestrogen- 
treated 22-day-old male and female rats increased significantly (P<0.01) 
on day 3 from 1400 to 1600h after which they decreased from 1700 to ISOOh 
(Fig.18). However, mean specific activities in the MPOA of these female 
rats were at baseline levels between 1500 - 1800h (Fig.19).
Measurements of mean specific activities of PNMT in the MBH of oil-treated 
22-day-old male rats at 1500, 1600 and 1700h on day 3 showed a pattern 
similar to that of oestrogen-treated 22-day-old males and furthermore, 
there were no significant differences between the mean specific activities 
of PNMT in the oil, and oestrogen treated rats at any of these times (Fig. 
20).
In contrast to oestrogen-treated 22-day-old females, there were no 
significant differences in the mean specific activities of PNMT in the MBH 
of oil-treated 22-day-old females or oestrogen-treated 16-day-old females 
at any time at which measurements were made (Tab.V).
Mean specific activities of PNMT in the MBH of oestrogen-treated 22-day- 
old female rats measured at 4-hourly intervals over days 2 and 3 showed 
a clear circadian rhythm. Peak levels of activity were reached at around 
1600h and lowest levels at around 2400h (Fig.21).
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Mean specific activities of PNMT (Pmol/h/mg) in the MBH of adrenal­
ectomized dexamethasone-oestrogen-treated infant rats:
Mean specific activities of PNMT (Pmol/h/mg Protein) in the MBH of groups 
of adrenalectomized female rats treated with oestrogen and dexamethasone 
and decapitated at 1500h, 1600h and 1700h on day 4 were similar to those 
of oestrogen-treated intact 22-day-old females. However, similarly 
adrenalectomized oestrogen-treated 22-day-old female rats showed baseline 
levels of mean PNMT activities in the MBH at these times in the absence 
of dexamethasone in the drinking water (Fig.22).
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Fig.18. Mean specific activity (IS.E.M.) of phenylethanolamine-N- 
methyl transferase (PNMT) in the mediobasal hypothalamus of 22-day-
) rats injected withold male ( ) and female (
Ijjg oestradiol benzoate (OE2) at 1200h on experimental day 1. Groups 
of animals were decapitated at hourly interval between 1400 - 1800h on 
day 3. The number of animals used is shown in brackets.
1600b : 1400h (P<0.01)
1600h : 1800h (PCO.Ol)
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Fig.19. Mean specific activity (iS.E.M.) of phenylethanolamine-N- 
methyl transferase (PNMT) in the medial preoptic area of 22-day-old 
female rats injected with Ijjg oestradiol benzoate at 1200h on experi­
mental day 1. Groups of animals were decapitated at hourly interval 
between 1500 - 1800h on day 3. The number of animals used is shown 
in brackets.
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Fig.20. Mean specific activity (IS.E.M.) of phenylethanolamine-N-methyl 
.transferase (PNMT) in the mediobasal hypothalamus of 22-day-old male 
rats injected with either oil ( ) or oestradiol benzoate
( ) at 1200h on experimental day 1 and decapitated at 1500h,
1600h or 1700h on day 3. The number of animals used is shown in 
brackets.
113
21
18
CT>
E
ô  15
E
û .
;1 12 
<
-g 9
O.
to
(f MBH 
S  OIL  
■  0E2
1400
i
i
1500 1600
Time (h )
1700 1800
Nû
N)
hO
0\
R R
ro
3
II
Ov
O
O
vo 
1 +
N)
CD
CD
VO
b
O',
O'.
cr
ro
ro
Vl
OJ
00
o
\û
00
"O
Vi
Ln
00
II
Ln
Z5
II
Vl
i?
Vi
1+
3
II
VJl
Lsl
CI
V>J
Ui
Ln
1 + 
O
00
0\
V>l
Ul
ro
1 +
o
Ô j
0\
VJl
VJ
ON
1 + 
ro
VjJ
VjJ
D
II
O n
=3
II
Vji
1 +
O
VjJ
V>J
VJl
1 +
' O  
-o
VJl
V>J
•o
o
o
VJl
o
1+
o
ro
O n
o
o
3
II
VJl
ro
-o
1 +  
1-^  
b
-o
o
o
zr
D
03
'<
CD
O
— *)
03
tO
CD
M
CD
03
rf
3
CD
D
CD
03
D
CD 
TD 
CD 
O  
h-'• 
-D
O
03
O
rr
H"
<
H-
CD
CD
O
-t
D
O
D
CD
X
■D
CD
i-J
I-"
3
CD
D
ri-
03
D
03
(jO
-H O 3z r H * CD
CD »— > CL
H»
3 03 O
C rt CT
3 03
CT h-> CD
CD ro 03
>-i o
o
f - '
O z r z r
—13 *<
o ■D
03 3 O
3 r r
r-" CL z r
3 03 03
03
r—> 03
CD r—>
Ë
c 03 CD
CD 3
CD D . O
D .
X -
— 1)
H* H* c3
CD 1—' 1-3
' O
CD CD C  ■
z r Q. "O
o CD
h-“
3 3 . O  ' 
-1)
I-" 13
3 r-j h-'
O ON
CT C
TD 03
03 CD 3
a 03
CL
CD rr IvJrr rx)
CD z r
o CL
O c 03
1-3 '<
1— '
o
03 i— '
~0
/\
O
O
CD
/X
o
b
r-"
D
CT
CD
M
<
03
'h - >
CD
Cl
c
h-'-
D
UD
CD
M
D
O
O
D
O' 
—t)
&
•<
V/J
CD
3
03
r—' 
CD
CD
rr
CD
CD
03 
D  
r-" 
3 
03 
t— ' 
CD
CD
CD
r-"
D
C_J.
CD
O
rr
CD
D.
cr 
r—> 
CD
<
CD
03
o
CD
•D
CD
n
H*
-1 3
H"
n
03
O
<
H"
rT
H-
CD
CD
R
CD
D
I— ■ 
CD
03
3
0  
h-‘ 
03
M"
D
CD
1
Z
J_
CD
rr
—3
■<
3
V/J
NO
1+ :
NO
CD
VJl
Vd
1 +
O
00
00
S
zr
H-
rJ
3T
CD
H»
rt
zr
CD
M
O
N T
O
H*
3
rr
zr
CD
114
Fig.21. Mean specific activity (iS.E.M.) of phenylethanolamine-N- 
methyl transferase (PNMT) in the mediobasal hypothalamus of 22-day-old 
female rats injected with Ijjg oestradil benzoate at 1200h on experimental 
day 1. Groups of animals were decapitated at 4-hourly intervals between 
1200h on experimental day 2, and 2000h on day 3. The number of animals 
used is shown in brackets. Horizontal white and black bars on the 
ordinate line indicates hours of light and dark respectively.
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Fig.22. Mean specific activity (iS.E.M.) of phenylethanolamine-N- 
methyl transferase (PNMT) in the mediobasal hypothalamus of groups 
of 22-day-old oestrogen-treated female rats with intact adrenals 
(   . ) or adrenalectomized ( ) and adrenalectomized
and treated with dexamethasone (
The number of animals used is shown in brackets.
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Discussion;
These experiments demonstrate that there is a significant increase 
(P<0.01) in the mean activities of PNMT in the MBH of both 22-day- 
old oestrogen-treated male and female rats at 1600h on day 3 (Fig.18). 
Such an effect was not seen in the MPOA of these female rats (Fig.19). 
The adrenaline concentrations in the MPOA and MBH of similarly 
treated rats were basal; with the exception of MBH of female rats 
which showed a significantly (P<0.01) higher increase in adrenaline 
concentration at 1600h (see Chapter 4, Figs. 16 and 17).
Interestingly, the MBH (a discrete area of the rat brain associated 
with the release of GnRH) of oestrogen-treated 22-day-old female rats 
showed both an increase in PNMT activity and an increase in adrenaline 
concentration at 1600h on day 3. In contrast, the MPOA (a discrete 
area of the rat brain associated with the synthesis of GnRH) of these 
rats was without such an effect. This observation of an increase in 
adrenaline concentration is confirmation of an earlier study in which 
the MBH of oestrogen-treated acutely ovariectomized rats at the expected 
proestrus showed an increase in adrenaline concentration and, further­
more a higher adrenaline turnover during the neural critical period 
(Mackinnon et al., 1985). Likewise, the MPOA of these rats was 
devoid of such a response. Using antibodies to PNMT, it was demon­
strated that cell bodies of adrenergic neurones, the axons of which 
project to the MPOA and MBH, are situated in the lateral reticular 
nucleus of the medulla (Hdkfelt et al., 1980). Moreover, employing 
both autoradiographic and immunohistochemical techniques, it was shown 
that both tritium labelled oestrogen and the enzyme dopamine—  ^  — 
hydroxylase were localised in the cells of the same region of the 
medulla (Sar & Stumpf, 1981). Based on these observations it can 
be proposed that oestrogen might act indirectly, via an adrenergic
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pathway on axon terminals of GnRH synthesizing and possibly TRH 
synthesizing neurones. In support of this suggestion is the observation 
that oestrogen does not concentrate in the cell bodies of GnRH immuno- 
reactive neurones (Shivers et al., 1983). Furthermore, a recent study 
has indicated that increased adrenergic actvity seen in the MBH of 
proestrous rats was related not so much to the arcuate nucleus as to 
the median eminence (Sheaves et al., 1984).
In contrast to oestrogen-treated female rats, male rats showed a 
significantly higher activity of PNMT in the MBH, while there was no 
increase in adrenaline concentration in response to an oestrogen stimulus. 
The absence of an increase in adrenaline concentration might be accounted 
for by an increase in its release or by enhanced monamine oxidase and/or 
catechol-o-methyl transferase activities at the MBH level. Whether these 
enzymes involved with monoamine oxidase metabolism are sexually differenti­
ated is not known. However, it could be argued that a continuous release 
of adrenaline into the hypothalamo-hypophysial portal vessels could result 
in baseline levels of adrenaline in the MBH of oestrogen-treated male rats. 
In similarly treated female rats an increase in concentration of adrenaline 
in the MBH might be due to its release having been inhibited. If this 
were the case then it is possible that central adrenaline might be 
operative at the level of the anterior pituitary. Possibly the presence 
of an increased level of adrenaline in the pituitary might inhibit the 
output of prolactin and LH in males. Furthermore, its possible dis- 
inhibition in females might cause the output of these hormones. One 
piece of evidence which supports this argument comes from a previous study 
in which with the use of high performance liquid chromatography and 
electrochemical detection, Johnston and his co-workers demonstrated that 
adrenaline concentrations in the protal blood were significantly higher 
than peripheral levels of adrenaline both in intact and adrenalectomized
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adult male rats (Johnston et al., 1983). With respect to adult females 
however, intensive studies of adrenaline concentrations in portal blood 
in this laboratory have failed to show any change in the levels during 
the oestrous cycle. At present these portal blood results reported by 
Johnston and co-workers are difficult to interpret. However, the 
results pertaining to the measurements of adrenaline in the portal blood 
from our laboratory suggest that central adrenaline might be operative 
at the MBH level rather than at the pituitary. If this were the case 
then it is likely that the adrenergic event in MBH represents a paracrine 
control of nerve terminals of releasing hormones (possibly TRH and GnRH), 
since there is no evidence to date for axo—axonal synaptic contacts 
between catecholaminergic and releasing-hormone neurones.
It is generally accepted that the removal of an inhibitory effect of 
endogenous opioids allows an enhanced turnover of catecholamine (NA & A) 
which apparently influences the release of GnRH (Kalra & Kalra, 1983).
In the light of this observation, one possible interpretation for the 
differences in adrenaline concentration present in the MBH of oestrogen- 
treated infant male and female rats could be that disinhibitory effect 
of the endogenous opioids was only expressed in females. The mechanism 
by which endogenous opioids exert their inhibitory/disinhibitory effect 
on catecholamines in still unclear.
It was of interest to ascertain whether the increase in PNMT activity in 
the male rats was due to the presence of exogenous oestrogen. Using the 
same experimental regime further studies demonstrated that oil-treated 
22-day-old males showed an increase in PNMT activity in the MBH similar 
to that seen in oestrogen-treated male rats (Fig.20). This suggests 
that an increase in PNMT activity is not due to a response to exogenous
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oestrogen. One possibility for this oil-treated rats could be that these 
have high levels of endogenous oestrogen due to aromitization of androgens. 
The oestrogen possibly in turn influences the cell bodies of PNMT containing 
neurones which project their axons to the MBH. Consequently, the oestrogen- 
induced newly synthesized PNMT might be axonally transported to the MBH, 
therefore resulting in an increase in its concentration. Possibly the 
PNMT containing neurones are responding at maximum level to its endogenous 
oestrogen system(s) and hence, exogenous oestrogen does not seem to have 
any effect in further increasing the PNMT activity.
Since a close temporal relationship seems to exist in the oestrogen- 
treated infant female rats between increased adrenaline concentration in 
the MBH and a massive output, of gonadotrophins (prolactin and LH) 2h later, 
it is possible that it might be dependant on an oestrogen-enhanced 
circadian influence on the adrenaline synthesizing enzyme. Subsequent 
measurements of oestrogen-stimulated PNMT activity in groups of rats 
decapitated at 4-hourly intervals from 1200h on day 2 to 2400h on day 3, 
showed that this was indeed the case, peak levels being attained at about 
1600h with a nadir in the early hours of the morning (Fig.21). There was, 
however, no evidence of an increase in PNMT activity in oestrogen-treated 
16-day-old females, oil-treated 22-day-old females (Table V), or in 
adrenalectomized oestrogen-treated 22-day-old females (Fig.22) at 1600h. 
These observations suggest that PNMT activity is inducible by both oestrogen 
and glucocorticoids since the presence of oestrogen and dexamethasone 
reinstated the enhanced levels of PNMT activity (Table V, Fig.22). These 
results are in agreement with other workers who found that gluocorticoids 
modulate both adrenal and brain PNMT activities (Wurtman, 1966; Pohorecky 
et al., 1969; Ciaranello, 1978). However, there is no evidence in the 
literature that brain PNMT is inducible by oestrogen. In a study pertaining
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to peripheral PNMT, however, it was demonstrated that repeated injection 
(s.c.) of oestradiol benzoate during late pregnancy in rats enhanced PNMT 
activity (Raja-Bukhari et al., 1976). This result is in agreement with 
the present finding that a single injection (s.c.) of oestrogen in 22-day- 
old female rats results in an incrase in PNMT activity.
In contrast to 22-day-old oestrogen-treated females, 16-day-old oestrogen- 
treated female rats did not show an increase in PNMT activity in the MBH 
at anytime on day 3 which was concomitantly associated with basal levels 
of adrenaline concentrations. This suggests that an increase in adrnaline 
concentration in the MBH of oestrogen-treated female rats is closely 
related to the age of the animal. It could be argued that a failure of 
16-day-old females to respond to an oestrogen stimulus was prevented by 
the presence of OC-foeto-protein ( ^ < FP) (see Chapter 3). However, an 
injection (s.c.) of stilboestrol which has a low affinity for c< FP was 
also without effect. It is possible, therefore, that a failure of the 
surge output of prolactin and LH in these animals was due to the absence 
of an increased concentration of adrenaline in the MBH.
In conclusion, present studies of the oestrogen-treated 22-day-old female 
rat suggest that there is a clear circadian rhythm in the MBH which is 
oestrogen and possible glucocorticoid dependant. Furthermore, an increase 
in PNMT activity in the MBH is paralleled by an increase in adrenaline 
concentration.
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Chapter Six
GENERAL DISCUSSION AND CONCLUDING PROPOSITIONS
This chapter attempts to highlight and correlate the main issues 
concerned with the oestrogen treated immature rats of 16-25 day-old 
(the ’infant rat model') which have arisen during the course of this 
work. Namely, the increase in adrenaline concentration in the MBH 
which invariably takes place 2h (1600h) before the oestrogen stimulated 
prolactin and LH surge outputs in 22-day-old female rats, but not in 
younger females or males at any age. This is in synchrony with the 
increase in activity of its synthesizing enzyme, PNMT. Furthermore, 
the increase in PNMT activity in the MBH of 22 day-old female rats is 
sensitive to the presence of steroids and shows a circadian rhythm 
with a peak value occurring at 1600h and a nadir at 2400h.
The immediate question which arises pertains to the choice of the
oestrogen treated infant rat as an experimental model for the study
presented in this thesis. It was selected for three reasons. One 
was that an injection of oestradiol benzoate (OEg) on experimental 
day 1 at as early an age as 21 days caused a surge output of prolactin 
at 1800h of days 2 and 3; while a surge of LH occurred only at 1800h 
on day 3 (Puig-Duran & Mackinnon, 1978a,b). Similar treatment of 
younger females and males at any age had no such effect. Secondly, it 
came from the studies performed both in this laboratory and elsewhere 
which showed that adult proestrus rats or long-term oestrogen treated 
ovariectomized rats when injected (i.p.) with SKF64139 (an inhibitor 
of central adrenaline synthesis) blocked the LH surge and consequent
ovulation (Coen & Mackinnon, 1981; Coen et al., 1982; Crowley & Cas-
Terry, 1981). In a third study it was found that a marked increase 
in adrenaline concentration and its turnover occurred both in the MPOA
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and MBH of adult proestrus rats during the proestrous 'critical period', 
prior to the preovulatory LH surge (Mackinnon et al., 1983). Using 
acutely ovariectomized adult rats it was found that the increase in 
adrenergic activity in the MBH, but not apparently that obtained in 
the MPOA, was oestrogen dependant (Mackinnon et al., 1985). It was 
suggested from these observations that oestrogen stimulated adrenergic 
activity in the MBH of adult rats might be concerned with the release 
of GnRH from their nerve terminals and an ensuing massive output of 
LH. It was therefore of interest to investigate the development of 
central adrenergic systems in the MBH concerned with the ontogeny and 
sexually differentiated output of LH in response to an oestrogen (OE2) 
stimulus. A possible approach to this problem was to measure adrenaline 
concentration and the activity of its synthesizing enzyme (PNMT) present 
in the MPOA and MBH of OE2 treated 16-^nd 22-day-old females and 22-day- 
old males at relevant times, prior to surge outputs of prolactin.and LH. 
This approach was undertaken throughout the present study.
The techniques which have been used throughout the present work were 
found to be valid and reliable. The rabbit antibody to ovine LH used 
in the RIA of LH cross reacts avidly with the rat LH and furthermore, 
shows negligible cross reactivity against FSH and TSH (Niswender et 
al., 1968). The observation that inter- and intra-assay coefficients 
of variation are within the acceptable range, further supports the 
validity of this assay (see Section 'A' of Chapter 2).
Due to consistency in the occurrence of landmarks for the location of 
the MPOA and MBH the use of micropunches as described by Palkovits 
(1973) was found to be highly reliable (see Section 'B' of Chapter 2).
The low values for inter- and intra-assay coefficients of variation 
and the authentic standards made up in the tissue supernatant and used
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in parallel to unknown samples for the radioenzymatic assays of both 
adrenaline and PNMT support the validity and reliability of these 
assays (see Sections ’C ’ and ’D ’ of Chapter 2).
The Lowry protein assay was used to measure small protein concentrations 
in the MPOA and MBH of the infant rat. This assay was highly reliable, 
and here again low values of inter- and intra-assay coefficients of 
variation were obtained. Furthermore, each assay included BSA standards 
in parallel to unknown samples (see Appendix).
The preliminary experiments as described in Chapter 3 were undertaken 
to confirm earlier findings from this laboratory with respect to the 
infant rat model. In 21~^or 22-day-old female rats marked increases in 
the concentrations of serum LH were obtained at a well defined time 
on day 3 (1800b), 54h after injection of oestrogen; while similarly 
treated 16 day-old females and males at any age showed no such effect 
(see Chapter 3). These results confirm the findings from this 
laboratory and extend earlier observations on the role of oestrogen in 
the facilitation of the release of LH in the serum of the immature 
female rat (Ramirez & Sawyer, 1965; Caligaris et al., 1972). A marked, 
but short-lived increase in adrenaline concentration in the MBH of 
oestrogen treated 22-day-old female rats was observed at 1600h on 
either day 2 or day 3, 2h before the surge output of gonadotrophins 
(prolactin with or without LH). But oestrogen treated 16-day-old 
females and 22-day—old males did not show such a response on day 3. 
Furthermore, in contrast to the results that were obtained in the MBH, 
the MPOA of oestrogen treated 22 day-old females did not show an 
increase in the adrenaline concentration (see Chapter 4). The increased 
levels of adrenaline in the MBH of oestrogen treated 22-day-old female 
rats, are much higher than those seen in the MBH of proestrus or
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acutely ovariectomized adult rats prior to the surge outputs of their 
gonadotrophins (Mackinnon et al., 1983; 1985). One possibility for 
this difference could be the way that MBH has been punched out. Since 
an earlier study revealed that a much higher proportion of adrenaline 
was present in the lateral and medial median eminence than in the 
arcuate nucleus (Sheaves et al., 1984); the MBH of OE2 treated 16-,and 
22-day-old females or 22-day-old males was punched out in such a manner 
as to include a large proportion of ME, but only small amount of . 
arcuate nucleus. The MBH is located outisde the blood-brain barrier, 
so it could be argued that the increase in adrenaline concentration 
which occurs in the MBH of eostrogen treated 22-day-old rats is not 
of central origin; but instead possibly reflects an increase in the 
output of adrenaline from the adrenals. However, the MBH of adrenal- 
ectomized-dexamethasone-oestrogen treated 22-day-old female rats 
showed an increase in adrenaline on experimental day 3, similar to 
those seen in the oestrogen treated intact rats (Personal Communication, 
A. Melcher). This finding suggests that an increase in adrenaline 
concentration in the MBH which has been measured in the present study 
does not reflect release from adrenals.
The important question which arises is whether or not there is a 
physiological role for the increase in central adrenaline concentration 
which occurs consistently not only in the MBH of proestrus or acutely 
ovariectomized oestrogen treated rats, but also in the oestrogen 
treated 22 day-old female rats. It has been suggested that central 
adrenaline in the MBH might be temporally related to the output of 
gonadotrophins. Whether it is temporally related to prolactin alone 
still remains to be seen. However, evidence that adrenaline might be 
a potent catecholamine in stimulating the output of prolactin came 
from a study in which steel cannulae were bilaterally implanted into
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the MBH of adult male rats (Day et al., 1982). This study showed that 
adrenaline had the greatest effect in evoking prolactin release 
following the bilateral micro-injctions of DA, NA or A into the MBH of 
these rats. Earlier studies from this laboratory and elsewhere 
demonstrated that a central adrenaline synthesis inhibitor (SKF64139) 
blocked the surge output of LH (Coen & Mackinnon, 1981; Coen et al., 
1982; Crowley et al., 1982). However, the use of this inhibitor is 
open to criticism. The observation that it possesses c< - receptor 
antagonistic properties (Toomey et al., 1981) and furthermore, inhibits 
monoamine oxidase activity (an enzyme responsible for metabolising 
catecholamines) (Fuller & Hemrick—Luecke 1983). It is possible there­
fore that blockade of the output of gonadotrophin by the use of SKF64139 
might possibly be due to i t s - r e c e p t o r  antagonistic properties; since 
catecholamines (NA & A) which might be involved in the regulation of 
the surge output of gonadotrophin are generally considered to mediate 
their response through these receptors (Everett et al., 1949; Sawyer 
et al., 1950; Drouva et al., 1982). This seemed to be the case since 
an almost complete reduction in central adrenaline concentration in the 
MBH of adult proestrus rats using a more recently synthesized drug was 
commensurate with an LH surge and ovulation (Sheaves et al., 1985b).
This drug 8,9-dichloro-2,3,4,5-tetra-hydro-lH-2-benzazepine (LY134046) 
has a much lower affinity for»(-receptors than SKF64139 (Fuller et 
al., 1981). Such evidence reduces the possibility of a role for central 
adrenaline in the output of LH, but it still remains to be seen whether 
or not this obtains in oestrogen treated infant rats. Whether the 
increase in MBH adrenaline is temporally related to the output of any 
other hormones such as TSH (Brown-Grant et al., 1977) or ACTH 
(Buckingham et al., 1978) is not known. For that matter neither is it
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known whether the infant rat model shows surge outputs of pituitary 
hormones other than those that have been measured (prolactin and LH) 
in this laboratory. To investigate this possibility the anterior 
and posterior pituitary hormones which are known to be released in 
response to an oestrogen stimulus should be measured in saline 
injected (control group) and in LY134046 treated animals. At present, 
however, it can only be said that an incrase in adrenaline concen­
trations in the MBH of eostrogen treated 22-day-old female rat are 
temporally related to the output of gonadotrophins. The hypothesis 
that an increase in adrenaline concentration in the MBH is possibly 
concerned with the output of gonadotrophins finds support in the 
present observations in which oestrogen stimulated 16-day-old females 
and 22-day-old males failed to show an increase in either adrenaline 
concentration in the MBH or a subsequent outpouring of gonadotrophins. 
Since £<-foeto protein ( (K-FP) concentrations in the blood decline 
steadily from birth to 21 days of age, it can be argued that the failure 
to show a gonadotrophin response to an oestrogen stimulus in 16-day-old 
rats was due to the presence of this oestrogen binding protein (Nunez 
et al., 1971). However, in rats treated with diethylstilboestrol (a 
synthetic oestrogen which does not bind avidly to cc - FP ) the 
gonadotrophin positive feedback response to synthetic oestrogen was 
also absent (Puig-Duran & Mackinnon, 1978b). A possible cause for this 
failure to show a surge output of gonadotrophins in response to 
synthetic oestrogen, could be the absence of an increase in adrenaline 
concentartion in the MBH of these rats.
The immediate question which arises as to how this increase in 
adrenaline concentration in the MBH of our rat model regulates the 
output of hormones such as prolactin and LH and possibly ACTH and TSH.
It has been discussed and, furthermore suggested that an increase in
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adrenaline might regulate the output of releasing hormones such as 
GnRH, CRH or TRH into the hypothalamo-hypophysial portal vessels 
possibly through a paracrine like effect (see the discussion section 
of Chapter 5). Whether the measurements of an increase in adrenaline 
concentration in the MBH of oestrogen treated 22-day-old female rats 
represents an accumulation of adrenaline within the nerve terminals 
or an increased output of adrenaline into the extravascular space 
or portal vessels is not known. A further question which arises as 
to how this increase in adrenaline concentration occurs. Measurements 
of PNMT activity in the MBH of oestrogen treated 16-^and 22-day-old 
female showed that this might be the possible candidate involved with 
the increase in MBH adrenaline concentration, since only 22-day-old 
animals showed an increase in PNMT at 1600h on day 3 in parallel to 
the increase in adrenaline (see Chapter 4 & 5). Furthermore, it has 
been shown previously that both in the adrenals and the brain, 
adrenaline concentrations vary directly with PNMT activity (Wurtman 
& Axelrod, 1966; Moore & Phillipson, 1975). What determines the 
increase in PNMT activity and consequently an increase in adrenaline 
in the 22—day-old females but not in 16—day-old females in response 
to an oestrogen stimulus is not known. However, a possible answer to 
this question comes from previous studies on opioids. Several studies 
have implied that the removal of an inhibitory effect of endogenous 
opioids allows an enhanced turnover of catecholamines (NA & A) which 
apparently influence the release of GnRH (Kalra, 1982; Kalra & Kalra, 
1983). It is possible that an increase in adrenaline concentration 
(presumably reflecting a higher turnover) (Hiemke et al., 1985) was 
due to the disinhibitory effect of the endogenous opioids on adrenaline 
neurones which might only be expressed in oestrogen treated 22-day-old 
females. Contrary to this concept that increased adrenaline concen­
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trations vary directly with PNMT activity was the observation that 
OE2 treated 22-day-old male rats also showed an increase in PNMT 
activity at 1600h (day 3) similar to that shown by the females; 
although no increases were found in adrenaline concentration in the 
MBH in response to oestrogen (see Chapter 4 & 5). PNMT was extracted 
from the MBH of either male or female rats and its activity measured 
under optimum conditions, it is possible therefore that there may be 
physiological differences in the enzyme activity of that found in 
males. The differences may be due to a number of factors such as 
the ratio of S-adenosylmethionine to homocysteine (Deguchi & Barchas, 
1970), the ionic strength of the enzyme environment (Cubeddu & Vargas, 
1977). Whether one or both these factors regulating PNMT activity are 
sexually differentiated is not known. This increase in PNMT activity 
in the MBH of 22-day-old male on day 3 is not only shown in oestrogen 
treated animals, but also in oil-treated animals (control group) (see 
Fig.20, Chapter 5). It has been suggested that the increase in PNMT 
activity in the control group, which was similar to that found in 
oestrogen treated rats, might be due to the presence of endogenous 
androgens and their metabolites as discussed previously (see Chapter 
5). However, in the MBH of 22-day-old female rat an increase in PNMT 
activity at 1600h on day 3 was not seen in the absence of an oestrogen 
stimulus (see Table VII Chapter 5). Furthermore, it has been observed 
that oil-treated 22-day-old females also showed baseline levels of 
adrenaline in the MBH in parallel to the low PNMT activity (Table VI, 
Chapter 4. However, the MBH of oil treated acutely ovariectomized adult 
rats showed low adrenergic activity (1430h - 1630h); this is the time 
when it was found to be much higher in intact proestrus and oestrogen 
treated acutely ovariectomized rats (Mackinnon et al., 1985). How does 
oestrogen regulate PNMT activity requires investigation. One possibility 
could be that oestrogen stimulates the genomic mechanisms of PNMT
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synthesis at the cell body level and the PNMT synthesized consequently 
is axonally transported to their terminals in the MBH. Support for 
this suggestion came from a study in which it was demonstrated that 
tritiated oestradiol concentrated in the nuclei of catecholaminergic 
neurones in the brain stem (Sar & Stumpf, 1981). This implies that 
genomic activation induced by oestrogen might be operative at the 
catecholaminergic neurone cell body level. Furtheremore, a retrograde 
tracing study has clearly shown that a dye (Fast blue) when injected 
into the MPOA of rats was histologically verified to be in the 3rd 
ventricle (Saper et al., 1983). This dye was later detected in PNMT- 
positive cell bodies located in the cell groups of the medulla 
obtongata. This provides evidence for the existence of adrenergic 
neurones projecting their axons from this cell group to the hypothalamus, 
Further support came from a study of the measurements of brain stem PNMT 
activity in adult rats at 4-hourly intervals over 24h period (Turner et 
al., 1981). This study showed the presence of a clear circadian rhythm 
which reached peak levels at 1500h. The study presented in this thesis 
(see Fig. 21, Chapter 5) has also shown that a circadian rhythm of PNMT 
activity in the MBH exists in the eostrogen treated 22-day-old females, 
with a peak occurring at 1600h and a nadir at 2400h. The one hour lag 
period between the peak of PNMT activity occurring in the brain stem 
and that of MBH might possibly represent the time taken by the fast 
exoplasmic flow responsible for transporting this enzyme from the cell 
bodies to their terminals in the MBH. Such a process has been shown to 
be operative at the rate of 100mm per day (Kapeller & Mayor, 1967). 
Whether the existence of PNMT circadian rhythms in the brain stem of 
oestrogen treated 22—day-old rats is also present, similar to that of 
adult rats, still remains to be seen. A study was performed by 
Brownstein et al., 1976 in which PNMT activity measured in the median
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eminence and arcuate nucleus of normal rats or in that of long-term 
rats in which the hypothalamus was completely deafferentated. This 
study showed that only a partial decrease in PNMT activity occurred 
after total hypothalamic deafferentation. Brownstein and co-workers 
postulated that the existence of adrenergic neurone cell bodies might 
be present in the hypothalamus in addition to that present in the 
brain stem. If this were the case then it is possible that oestrogen 
might induce genomic activation in the adrenergic cell bodies at the 
hypothalamic level as well.
The increase in PNMT activity in the MBH of 22-day-old females at 
1600h on day 3 is dependant not only on an increase in oestrogen 
concentrations in the plasma, but also on the presence of plasma 
glucocorticoids. Since it is only adrenalectomized steroids (oestrogen 
and dexamethasone) treated animals that showed an increase in PNMT 
activity similar to those of oestrogen treated intact rats; while 
adrenalectomized-oestrogen treated animals (control group) did not show 
such a response (see Fig.22, Chapter 5). How these corticosteroids 
regulate the PNMT activity is not fully understood. One possibility 
could be that corticosteroids are operative in inhibiting the proteolysis 
of this enzyme . At present there is no direct evidence available for 
the regulatory role of corticosteroids in inhibiting the proteolysis 
of an enzyme in vivo. However, thermal dénaturation studies of the 
PNMT extracted from adrenals of either normal or hypophysectomized rats 
showed that the PNMT activity of hypophysectomized animals was much more 
vulnerable than that of normal rats (Ciaranello et al., 1978). Further­
more, the presence of ACTH or dexamethasone in the plasma of hypophys­
ectomized rats reduced the vulnerability to thermal dénaturation 
in vitro. This difference in PNMT activity, as measured under optimum 
conditions after heat dénaturation at 50®C in the normal and hypophys-
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ectomized animals thought to be due to the presence of a stabilizing 
factor, S-adenozylmethylmethionine (SAM); since the stabilizing factor 
was only present in the PNMT extracted from normal rats. Ciaranello 
and his co-workers postulated that an increased susceptibility of 
PNMT to heat dénaturation in vitro possibly reflects the increased 
susceptibility of this enzyme to intracellular proteolysis in vivo.
It is possible that endogenous corticosteroids induce the binding of 
SAM to the PNMT. Binding of SAM might alter the enzyme conformation 
in such a manner that it is no longer preferred substrate for 
proteolysis. In contrast to the prsent finding that glucocorticoids 
stimulate PNMT activity in the MBH of oestrogen treated 22-day-old 
female rats at 1600h (day 3), an injection (s.c.) of corticosterone 
failed to elevate brainstem PNMT activity within Ih compared to either 
vehicle injected or uninjected controls (Turner et al., 1981). How­
ever, the long-term effect of glucocorticoids in enhancing the PNMT 
activity cannot be ruled out since adrenalectomized—dexamethasone— 
oestrogen treated animals have shown a significant rise (PCO.Ol) at 
1600h compared to adrenalectomized-oestrogen treated animals (see Fig. 
22, Chapter 5). Whether or not the onset of PNMT circadian rhythms are 
stimulated by corticoisteroids in the oestrogen treated rats still 
remains to be seen. However, a possible effect of glucocorticoids in 
enhancing the PNMT activity in the MBH and consequently adrenaline 
concentration in the MBH of oestrogen treated rats finds support from 
the present observations. Oestrogen treated 16-day-old females in 
which apparently corticosteroid rhythms have not yet been established 
(Ader, 1969; Campbell & Ramaley, 1974) did not show an increase in 
PNMT activity, not did they show an increase in adrenaline (see 
Chapters 4 & 5). Further work is required to investigate changes in 
the concentration of serum corticosteroids in oestrogen treated 16-,
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and 22-May-old remale rats. In adult rats corticosteroid rhythms 
appear to be related to, though not necessrily dependant on circadian 
rhythms of hypothalamic CRH (Seiden & Brodish, 1972) and serum ACTH 
concentrations (Buckingham et al., 1978). Since a surge output of 
ACTH at proestrus in adult rats occurs in synchrony with the pre­
ovulatory surge of gonadotrophins (Buckingham et al., 1978). The 
pssibility exists that increase in PNMT activity and adrenaline 
concentrations in the MBH which precede by 2h a massive output of 
gonadotrophins (prolactin and LH) might be more closely related to 
ACTH output.
In conclusion, a temporal relationship (not necessarily specific) 
exists between increased adrenaline concentrations in the MBH of 
oestrogen treated 22 day-old female rats and a surge output of 
gonadotrophins (prolactin with or without LH) 2h later. This re­
lationship apparently depends on an oestrogen and possibly gluco­
corticoids stimulated circadian rhythm of PNMT activity. Failure of 
an increase in the activity of PNMT and concentration of adrenaline 
in the MBH of oestrogen treated 16- day-old females; and furtheremore, 
disruption of the synchrony between increased PNMT activity and 
adrenaline concentration%in the MBH of similarly treated males might 
be responsible for the absence of an outpouring of gonadotrophins 
(prolactin and LH).
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APPENDIX
PROTEIN ESTIMATION
The NaOH hydrolysate obtained by dissolving the pellet in 2M NaOH [see 
sections on radioenzymatic assay of catecholamines and phenylethanola­
mine-N-methyl transferase assay] was taken for estimation of protein 
content based on the method of Lowry et al. (1951).
1. Reagents
(a) Bovine serum albumin (BSA) fraction V [Sigma Chemical Co., 
U.K.] stock solution: lOOmg BSA was weighed in a silanized glass
scintillation vial and added to it 10ml of 2M NaOHv It was left for
gentle stirring until dissolved completely and then kept at 4°C until
used. This solution can be used for at least one month (the maximum 
storage time used) if kept at 4°C.
(b) Standards:
jjg BSA in 50jj1 sample Standard soln.
0 2M NaOH
5 9.9ml 2M NaOH + IOOjjI Stock BSA
10 9.8ml 2M NaOH + 200j j 1 Stock BSA
15 9.7ml 2M NaOH + 300j j 1 Stock BSA
(c) Solution 1:
(a) 10ml 2% (w/v) NagCOs
(b) 0.1ml 1% (w/v) CuSO^-SHzO
(c) 0.1ml 1% (w.v) NakTartrate
The above three were kept as stock solutions at 4°C and mixed on 
the day of assay in this ratio (10:0.1:0.1).
(d) Solution 2:
50% (v/v) Folin Ciocalteu (F & C) reagent.
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NagCOs, CuSO^ and NakTartrate were obtained from Sigma Chemical Co.,
U.K. and F & C reagent was obtained from B.D.H. Ltd., U.K. Concentrated 
solution of F & C reagent and the solutions of Na2Cog, CuSO^ and 
NakTartrate keep very well for months if kept at 4°C.
Solutions 1 and 2 were made up fresh for each experient.
2. Standard Assay Procedure
To ensure that proteins are digested completely, the LP2 capped tubes 
containing the hydrolysate were heated at 60°C for one hour. 2 x 50pl 
of the soluble hydrolysate were added by Hamilton syringe to glass tubes
3
[2" X /8"] containing 1ml of 'solution 1'. Ten minutes later, 0.1ml 
'solution 2' was added followed immediately by vortex-mixing briefly.
The absorbance was measured against reagent blank at 750nm after one 
hour using Perkin-Elmer spectrophotometer and BSA standards were run in 
parallel.
A typical standard protein curve is shown in Fig.A. and the unknown 
samples were read off this curve. A range of unknown tissue samples
which were read off the curve is shown by the hatched area. Duplicate
measurements in the same assay that deviated by more than 10% from their 
mean value were discarded and the assay repeated.
3. Calculations
Although some authors have reported the determination of protein content 
present in the homogenate (Brownstein et al., 1974; Palkovits et al., 
■1974), Loullis et al. (1979) made use of the pellets for the determination 
of protein content. Since 2 x IOjjI of the actual supernatant is an 
essential requirement [see Section ' C  of Cliapter 2 . ] for the 
determination of catecholamines and adrenaline concentration is much 
lower than dopamine and noradrenaline, it was not feasible to use the 
homogenate for protein determination. The protein content was therefore
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measured in the pellets after digestion in 2M NaOH, accordance with 
Loullis et al. (1979). A preliminary study showed that 60% of protein 
appeared in the pellet and the remainder in the supernatant. Correction 
for missing 40% was made in order to get the total protein. Validity 
of this procedure was indicated by its consistency in protein content 
of the pellets from sample to sample. The determination of the total 
protein content was routinely performed by using a pre-programmed 
computer [Apple II].
Precision
The precision is a measurement of coefficient of variation as discussed
in section 'A' of this chapter. Intra - and inter - assay coefficients
of variation were determined by using 8 aliquots of the same sample
within the same assay and in separate assays respectively.
Intra-assay coefficient of variation:
C.V. (%) = X 100
Mean
C.V. = 4.22%
Inter-assay coefficient of variation:
C.V. = 6.20%
5. Sensitivity and Specificity
On the basis of twice the standard deviation (2 x S.D.) of blanks, the 
sensitivity resulted in 0.99 pg. However, the unknown samples never 
approached this limit since the estimated protein content ranged from 
3jjg - 7jjg [shown by hatched area in Fig.A].
Specificity is determined at two steps which lead to the final colour
(i) protein reaction with the alkaline copper to form protein- 
copper complex,
(ii) reduction of phosphomolybdate with protein-copper complex 
to give blue colour.
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Fig.A. Relationship of protein (BSA) content to absorbance (750nm) 
as determined by the Lovry-protein assay.
The protein range (3 - 7pg) in the NaOH extract of the standard 
assay for brain punches is shown by the hatched area.
Each point is a mean of 3 determinations.
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